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ABSTRACT 
 
Application of Vaccination Protocols to Manage Beef Cattle Productivity and Mitigate 
Production Risk. 
(May 2009) 
Willy Justin Horne, B.S., Texas A&M University; M.S., Texas Tech University 
Co-Chairs of Advisory Committee:  Dr. Jason E. Sawyer 
Dr. Andy D. Herring 
 
 The U.S. beef industry is very large with many inter-connected facets.  Nutrition and 
health are key components of a system striving to compete economically while striving to 
produce a high quality product.  The decisions made in one part of the system may often 
determine outcomes in the other parts of the system.  Therefore, it is necessary to look at the beef 
industry in a systems type of framework.  Each management decision is likely tied to a result that 
may alter several other management questions.   
 At the cow/calf level, producers must decide whether or not to vaccinate their calves.  
Vaccination leads to reduced disease incidence and severity in the feedyard, thus being beneficial 
to the feeder.  However, if the feedlot does not respond economically in any way, producers may 
feel that it is not warranted to vaccinated calves.  Pre-conditioning programs work in the same 
manner as they may have beneficial effects for the feeder but not for the harvester.  Therefore, 
pre-conditioning may not be a program that is valued back to the farm level.  Answers to these 
kinds of questions are hard to ascertain.  Each segment has its own demands and drivers, which 
determine how much it can reward to other segments for their efforts.  Because the market is 
continuously changing, the target rewards are changing as well.  Therefore targets cannot be 
 
 iv
theorized, rather exact relationships should be shown.  In this dissertation, it is intended to 
characterize the relationships vaccination protocols and other management strategies can have on 
various aspects of cattle performance in various industry segments.   
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CHAPTER I 
INTRODUCTION: THE IMPORTANCE OF SYSTEMS THINKING  
IN BEEF CATTLE PRODUCTION RESEARCH 
 
 Systems thinking is a framework that is based on the belief that the component parts of a 
system can best be understood in the context of relationships with each other and with other 
systems, rather than in isolation.  The only way to fully understand why a problem or element 
occurs and persists is to understand the part in relation to the whole (Capra, 1996).  The U.S. 
beef production system is a multi-faceted industry with many inter-related parts.  Each segment 
of the beef industry represents a phase in the life of the beef animal.  While these phases may or 
may not be merely a continuation of the previous phase, the biological system within that phase 
is undoubtedly linked to all of the phases.  No matter how old the animal is, it still has to have 
adequate nutrition, water, and air to breathe.   
For the beef animal, dietary conditions require that nutrients supply energy and protein 
from which life is sustained at the cellular level.  Water also must be provided so that cell 
function can occur.  Oxygen has to be supplied so that respiration may occur.  At the most basic 
level, these three things must be available for life to continue.   
In the biological system the most basic element of life is the cell.  The properties of all 
cells are the same.  These properties are: (1) Cells must be able to self-replicate and assemble.  A 
single bacterial cell placed in a sterile nutrient medium can give rise to a billion identical 
“daughter” cells in 24 hours.  Each cell contains thousands of different molecules, some  
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extremely complex; yet each resulting cell is a faithful copy of the original, its construction 
directed entirely from information contained within the genetic material of the original cell.  (2) 
The cells must be able to sense and respond to alterations in their surroundings by adapting their 
internal chemistry (Nelson and Cox, 2005).        
Despite these common properties, and the fundamental unity of life they reveal, very few 
generalizations about living organisms are absolutely correct for every condition.  This poses a 
significant problem when trying to optimize a production system made up of living animals 
under a variety of management types and environments.  In fact, this means that no holistic 
approach to the industry will be correct for every animal in every situation.  However, it is 
possible to identify key parts of a system and make generalizations as to how the animal will 
respond based on research and experience.  This is where a systems approach to identifying best 
operational conditions of the beef industry is needed, a broad scope, but narrow focus of each 
part from the cell level upwards.  
Many, many books have been written examining every part of the biological system.  
Many more have been written outlining the entire system and have tried to tie all of the pieces 
together.  Without all knowing power, we shall never be able to put everything together.  But by 
using the systems approach we can merely outline the big components of a beef animal’s life 
from the time it is born to the time it is harvested. 
To outline a beef animal’s phases of life from birth to harvest, it is easiest to characterize 
the phases into three main production groups.  The three main groups can be characterized as the 
cow/calf, stocker, and feedlot phases.  These groups may intersect, overlap, or be completely 
separate depending upon the particular situation.  Two main components of life exist in all of 
these sectors; health and nutrition.  At the basic level, health and nutrition does not change from 
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one sector to another.  However, management practices applied alter the health and nutrition 
status of the animal.  This literature review will address the interaction that health and nutrition 
status have in the life of the animal.  The health aspects must be broken down into subcategories 
of basic immune system, calf-hood immunity, and cytokines.  Then vaccination interactions will 
be examined with the above subcategories.  Management applications on stress and nutrition and 
its interaction with vaccination applicability can then be looked at.  To move slightly more broad 
again, nutrition can be broken into the subcategories of minerals, pre-feedlot nutrition, and 
preconditioning exercises.  Each of these pieces is meant to show that this system works as a 
holistic system and that a change in any one part will often lead to changes in the rest. 
Health 
Health of an animal can refer to any part of the overall condition of the animal.  The two 
systems primarily responsible for the overall condition of the animal are the immune and 
endocrine systems.  These systems work together to keep homeostasis within the animal.   
   Immune system. The immune system works to protect the animal from foreign 
substances, including microbes, as well as macromolecules such as proteins and polysaccharides, 
regardless of the physiologic or pathologic consequence of such a reaction (Abbas and Lichtman, 
2005).  The mechanisms of the immune system can be categorized into those that are dependent 
on antigen recognition by antibodies or lymphocytes (specific, acquired) and those that occur 
independent of such recognition events (nonspecific, innate, native).  Although specific and 
nonspecific mechanisms can each act independently to promote host defenses, more often they 
act in combination and therefore provide greater protection than either system can alone 
(Barrington and Parish, 2001). 
 
4 
 
 
Non-immune defense mechanisms include effects such as enzymes in secretions, acids in 
the stomach, fatty acids in epithelium, and normal flora that colonize mucosal surface.  The 
principal components of innate immunity are (1) physical and chemical barriers, such as epithelia 
and antimicrobial substances produced at epithelial surfaces; (2) phagocytic cells (neutrophils, 
macrophages) and natural killer (NK) cells; (3) blood proteins, including members of the 
complement system and other mediators of inflammation; and (4) proteins called cytokines that 
regulate and coordinate many of the activities of the cells of innate immunity.  The mechanisms 
of innate immunity are specific for structures that are common to groups of related microbes and 
may not distinguish fine differences between foreign substances.  Innate immunity provides the 
early lines of defense against microbes (Abbas and Lichtman, 2005).  Non-immune defense 
mechanisms can be suppressed by stress, malnutrition, low level infections, or exposure to toxins 
(Barrington and Parish, 2001).   
In contrast to innate immunity, there are other immune responses that are stimulated by 
exposure to infectious agents and increase in magnitude and defense capabilities with each 
successive exposure to a particular microbe.  Because this form of immunity develops as a 
response to infection and adapts to the infection, it is called adaptive immunity.  The adaptive 
immune system has an extraordinary capacity to distinguish among different, even closely 
related microbes and molecules, and for this reason is also called specific immunity (Abbas and 
Lichtman, 2005).   
There are two types of adaptive immune responses, referred to as humoral immunity and 
cell-mediated immunity, that are mediated by different components of the immune system and 
function to eliminate different types of microbes.  Humoral immunity is mediated by molecules 
in the blood and mucosal secretions, termed antibodies, that are produced by cells called B 
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lymphocytes (also known as B cells).  Cell-mediated immunity, also called cellular immunity, is 
mediated by T lymphocytes (also known as T cells).  Intracellular microbes, such as viruses and 
some bacteria, survive and proliferate inside phagocytes and other host cells, where they are 
inaccessible to circulating antibodies.  Defense against such infections is a function of cell-
mediated immunity, which promotes the destruction of microbes residing in phagocytes or the 
killing of infected cells to eliminate reservoirs of infection (Abbas and Lichtman, 2005).   
Protective immunity against a microbe may be induced by the host’s response to the 
microbe or by the transfer of antibodies or lymphocytes specific for the microbe.  The form of 
immunity that is induced by exposure to a foreign antigen is called active immunity because the 
immunized individual plays an active role in responding to the antigen.   
Immunity can also be conferred on an individual by transferring serum or lymphocytes 
from a specifically immunized individual.  The recipient of such a transfer becomes immune to 
the particular antigen without ever having been exposed to or having responded to that antigen.  
Therefore, this form of immunity is called passive immunity (Abbas and Lichtman, 2005).   
Calf immunity.  Upon leaving the sterile uterine environment, neonates are exposed to 
environmental conditions that are laden with microorganisms. Although they are capable of 
mounting an immune response, neonates are best characterized as being immunonaive 
(Barrington and Parish, 2001).  This inability to initiate a successful immune response is 
attributable to the immaturity of protective mechanisms and the time delay in the initiation and 
production of mechanisms necessary for the generation of humoral and cell-mediated immunity.  
Passive immunization is a useful method for conferring resistance rapidly, without having to wait 
for an active immune response to develop.  An example of passive immunity, in most mammals, 
is the transfer of maternal antibodies to the fetus, which enables newborns to combat infections 
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before they acquire the ability to produce antibodies themselves (Abbas and Lichtman, 2005).  
However, in bovine animals this passive transfer does not occur in utero.  Maternal 
immunoglobulins, immune cells, and various cytokines are supplied to the bovine neonate 
through colostrum because the syndesmochorial structure of the placenta prevents prepartum 
transfer (Barrington and Parish, 2001).  The ingestion of colostrum is essential for providing 
neonates with immunologic protection during at least the first 2 to 4 weeks of life (Chase et al., 
2008). 
In normal, full-term neonatal calves, colostral absorption is accomplished through 
intestinal cells by the neonatal receptor FcRn and endocytosis using “transport vacuoles” (Israel 
et al., 1995; Bainter, 2007).  This absorptive capacity begins to decrease 6 to 12 hours after birth 
and ends by 48 hours after birth (Sangild, 2003; Bainter, 2007).  Calves that ingest colostrum 
shortly after birth have significant concentrations of immunoglobulin (Ig) in serum, whereas 
colostrum-deprived calves have only trace amounts of immunoglobulin during the first 3 days of 
life (Clover and Zarkower, 1980).  Levels of circulating IgA, IgG1, and IgG2 do not reach 
appreciable levels in colostrum deprived calves until 16 to 32 days after birth (Husband and 
Lascelles, 1975).   
Colostrum also provides the calf with cytokines (Hagiwara et al., 2000).  These 
immunologic hormones help in the development of the fetal immune response.  Interleukin (IL) 
1-beta (IL-1 beta), IL-6, tumor necrosis factor (TNF-α), and interferon-gamma (IFN-γ)are 
present in bovine colostrum and are associated with a proinflammatory response and may help in 
the recruitment of neonatal lymphocytes into the gut to aid in normal immune development.  The 
high levels of two anti-inflammatory cytokines, IL-4 and transforming growth factor beta-1, 
suppress local secretion of proinflammatory cytokines in the intestine and allow gut microbial 
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fermentation (Chase et al., 2008).  A serum IgG concentration assay at 48 hours of age can be 
used as an objective measure for defining the threshold between adequate passive transfer and 
failure of passive transfer (Guidry et al., 1980). 
Another component of colostrum is cells.  Colostrum contains between 1 x 106 and 3 x 
106 cells/mL, which are almost exclusively leukocytes (Lee et al., 1980).  Animals that receive 
colostrum containing maternal leukocytes develop antigen-presenting cells faster (Reber et al., 
2005) than animals that do not receive colostrum.  This is important because antigen-presenting 
cells are the keystone cell for development of an acquired immune response to pathogens or 
vaccines (Chase et al., 2008). 
  Certainly one of the major challenges in developing an active immune response in 
young calves has been interference from maternal immunity through colostrum (Morein et al., 
2002).  This problem has been demonstrated with several pathogens, including BVD (Ellis et al., 
2001), bovine herpesvirus-1 (BHV-1) (Lemaire et al., 2001), and Mannheimia (Pasturella) 
haemolytica (Hodgins and Shewen, 1998).  In these trials, development of an immune response 
to vaccination was measured by the presence or absence of antibodies in the blood of the 
vaccinated animal.  Assays that measure antibodies detect humoral immunity, but give no 
information about T cell immunity.  In general, T helper cell (CD4 T cells) responses are 
assumed to occur concurrently with humoral responses due to the requirement for T cell help in 
generation of a humoral response.  Measuring serum antibody does not provide a complete 
picture of the animal’s immune response because the activities of the cell mediated immunity are 
not evaluated (Endsley et al., 2003).   
Nonnecke et al. (2005) found that vaccination of week-old dairy calves with M. Bovis 
resulted in non-existent antibody responses.  However, the early vaccination did induce a Th1 
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response that was comparable to adult cattle sensitized in an identical manner.  Responses were 
characterized by antigen-induced proliferation of CD4 T cells and secretion of IFN-γ and TNF-α.  
It was concluded that the bovine neonate can respond completely to a potent inducer of cell-
mediated immunity but that the animal’s maturity influences antigen-elicited antibody responses.   
Furthermore, circumvention of maternal antibody neutralization is affected by 
concentrations of antibody delivered to the calf through colostrum.  Producers typically 
vaccinate calves after maternal antibody concentrations decrease (van Oirschot et al., 1999).  
Depending on the immune status of the dam and the efficiency of colostral immunoglobulin 
transfer, the maximum maternal antibody titers derived from colostrum should be less than 1:32.  
This titer level may be reached anywhere from 70 to 160 days of age (Munoz-Zanzi et al., 2002).  
This leaves a period of time during which calves are vulnerable to infection.   
It has been shown that a single dose of modified-live virus (MLV) vaccine containing 
BVD administered to calves at 4 to 5 weeks of age could stimulate a strong protective immune 
response in the face of high concentrations of maternal antibodies (Zimmerman et al., 2006).  In 
that study, a viral challenge was included to determine that the protective response did indeed 
protect the calves from challenge later in life.  Research is limited using challenges to enforce the 
idea that a cell mediated response can indeed be produced and will protect the calf from future 
challenges. 
There has been research demonstrating that vaccination in the face of maternal antibodies 
can induce a cell mediated response including the production of CD4 and CD8 T cell responses 
as well as production of certain cytokines even though an antibody response was not produced 
(Endsley et al., 2003).  The detection of cytokine production is important because cytokines 
function to mediate the inflammatory processes of the human body (Romagnani, 2000).   
 
9 
 
 
Cytokines.  Cytokines can be categorized by the many different functional activities they 
mediate, and any cytokine may have multiple effects.  Some cytokines activate innate immune 
cells such as phagocytes and natural killer cells and stimulate their participation in inflammatory 
processes, whereas others suppress and resolve inflammation.  Several cytokines promote the 
activation of and antibody production by B cells, as well as antibody class switching of B cells.  
Certain cytokines have effects further upstream in the ontogeny of cells, in that they direct the 
maturation and mobilization of distinct classes of cells (Roth, 2007).  Successful defense against 
the majority of infections requires an early T helper (Th1) cell-mediated inflammatory response 
(type 1 response).  Interferon-γ, interleukin-2 (IL-2), and tumor necrosis factor α (TNF-α) are 
particularly important type 1 cytokines.  Type 2 responses (those mediated by Th2 cells) are 
generally characterized by high antibody production and often by recruitment of eosinophil and 
mast cell activity.  Of the type 2 cytokines, IL-4, IL-10, and IL-13 are among the most dominant 
and best characterized.  Importantly, cytokines from type 1 responses tend to suppress type 2 
responses, and vice versa, so that one or the other response predominates (Roth, 2007). 
The Th1 type cytokines are produced mainly by lymphocytes, antigen presenting cells 
(APCs), and natural killer cells (NK-cells).  They induce cell-mediated immunity (Bais et al., 
2007).  Th2 type cytokines (IL-4, IL-6, IL-8, IL-10), produced by lymphocytes and mast cells, 
are immuno-inhibitory for cell-mediated responses and predominately induce humoral immunity 
(Clerici et al., 1998; Spellberg and Edwards, 2001).   
Cytokines may also be categorized as proinflammatory and anti-inflammatory.  The 
proinflammatory cytokines such as TNF-α, IL-1 and IL-8 induce the mobilizing immune system 
cells to proliferate and produce more cytokines; thus initiating the inflammatory cascade.  Anti-
inflammatory cytokines such as IL-10 function to dampen or control the inflammatory response.  
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Proinflammatory cytokines are primarily responsible for initiating a potent defense against 
exogeneous pathogens (Cruz et al., 2008).  In contrast, anti-inflammatory cytokines are crucial 
for down regulating the elevated inflammatory process and maintaining homeostasis for the 
correct functionality of vital organs (Howard et al., 1993).  Homeostasis is critical for animal 
survival.  Excessive production of any of these mediators may significantly contribute to shock, 
multiple organ failure, and death (van Dissel et al., 1998; Taniguchi et al., 1999; Fasshauer et al., 
2003). 
Although all essential immune components are present in neonates at birth, many of the 
components are not functional until calves are at least 2 to 4 weeks of age and may continue to 
develop until puberty (Reber et al., 2006).  The placenta produces progesterone, prostaglandin 
E2, and cytokines (eg, IL-4 and Il-10) that suppress cell-mediated and memory (Th1) responses.  
As part of the parturition process calves produce high levels of cortisol that remain elevated for 
the first week of life (Mao et al., 1994).  The cumulative effect of these hormones is to suppress 
immune responses and direct the immune response away from the Th1 response.  These 
hormones also promote short-term Th2 immune responses, particularly production of IgM 
(Chase et al., 2007).   Endogenous production of IgM in colostrum-deprived calves does not 
begin to appear in circulation until 4 days after birth and does not reach expected functional 
levels until 8 days of age.  Levels of the calf’s own circulating IgA and IgG have been shown to 
not reach appreciable levels until 16 to 32 days after birth (Husband and Lascelles, 1975).   
Experiments performed in 2-day-old mice have demonstrated that potent adjuvants can 
break the Th2 bias.  Sendai virus vaccines adjuvanted with immune-stimulating complexes 
stimulated a Th1 immune response prominent in IFN-γ, whereas a Sendai virus vaccine 
adjuvanted with the traditional Al(OH)3 adjuvant produced a Th2 response (Morein et al., 2002).  
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To date, only two experimental vaccine systems have demonstrated the ability to break the Th2 
bias in young livestock.  The first experiment used small DNA sequences, called 
oligodeoxynuclotides, as a vaccine adjuvant given to day-old piglets.  The piglets responded with 
significant cellular proliferation and IFN-γ production to the adjuvant.  They also produced 
significant antibody titers within the first week after vaccination (Linghua et al., 2006).   
Neonatal calves vaccinated subcutaneously 8 hours after birth with attenuated 
Mycobacterium bovis developed effective Th1 immunity, but failed to produce significant 
antibody responses (Nonnecke et al., 2005).  Chase et al. (2008) reported that the take home 
message from those two studies was that cell-mediated responses to vaccines can be induced 
early; however, animals may need to be as old as 3 to 4 weeks before vaccines induce 
corresponding antibody responses that develop 10 to 14 days after vaccination.   
Stocker and feedlot cattle vaccines.  In cattle over 3 months of age, many vaccines have 
demonstrated the ability to induce the Th2 response which yields antibody formation.  BVD 
vaccines have been available for use in cattle for over 40 years in the U.S (Fulton, 2007).  Over 
160 BVD vaccines alone were listed in the Compendium of Veterinary Products (2003).  These 
vaccines met all of the requirements for safety, purity, potency, and efficacy by the USDA’s 
Center for Veterinary Biologics Code of Federal Regulations Sections 113.311 and 113.215 
(available at: www.Aphis.usda.gov/vs/cvb/index.htm).  The requirements for efficacy are that the 
vaccines induce protection against clinical illness after challenge with virulent disease.   
Nearly all of the presently licensed vaccines are conventional vaccines containing either 
killed or modified-live (MLV) whole bacteria or viruses.  Most of the killed vaccines contain 
either aluminum hydroxide or oil and water adjuvants, which have been used for many years.  
Recently, vaccines have been approved with newer-type adjuvants (Roth and Henderson, 2001). 
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Vaccine products may contain high numbers of MLV or killed organisms, subunits of killed 
organisms, or inactivated toxins (waste products) of organisms known to cause a particular 
disease (Faries, 1999).   
A vaccine containing inactivated toxins is called a toxoid while a vaccine containing 
killed bacteria is called a bacterin.  Adjuvants are added to bacterins to increase effectiveness of 
the antigens.  Adjuvants slow the release of the antigen into the body and prolong the immune 
response (Faries, 1999). 
Vaccines can be classified as either noninfectious or infectious.  Noninfectious vaccines 
are unable to infect and replicate.  They are usually weaker in their ability to simulate an immune 
response (Faries, 1999).  Noninfectious vaccines include killed vaccines, bacterins, toxoids, 
leukotoxoids, and chemically altered vaccines.  Infectious vaccines contain a virulent organism 
that is modified or reduced (attenuated) so that it no longer causes disease, but it is able to infect 
and replicate.  A MLV vaccine is an infectious vaccine that establishes a desired infection in the 
vaccinated animal.  Immunity prevents the desired infection from being established.  Infectious 
vaccines include MLV vaccines that are not body temperature sensitive, and MLV vaccines that 
are chemically altered (Faries, 1999). 
The advantages of a MLV vaccine are that they require lesser amount of virus than do 
killed vaccines because the pathogen replicates in the host to build immunogenic mass.  In 
general, MLV vaccines require only one dose for initial immunization but do require more rigid 
handling procedures because the vaccine virus is susceptible to inactivation by chemicals and/or 
exposure to higher temperatures (Fulton, 2007).  Upon administration of a MLV vaccine, the 
viral strains replicate in the susceptible bovine, resulting in viremia (Cortese et al., 1997; Grooms 
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et al., 1998; Fulton et al., 2003).  The duration of viremia is between 3 and 7 days after which the 
virus is cleared as the calves develop antibodies (Fulton et al., 2003). 
Killed vaccines have advantages and disadvantages.  From a production cost standpoint, 
killed vaccines are expensive because larger amounts of virus are required to prepare each dose 
of the vaccine as compared to MLV vaccines and there is the added cost of adjuvants.  The 
process of virus inactivation for the production of killed vaccines is likely to also inactivate 
possible contaminants if any; however, this is not guaranteed unless the final product is tested for 
replicating virus.  One disadvantage is that two doses are generally required for immunization.  
The first dose acts as acts as a priming method by developing memory cells, and the second dose 
acts as a booster.  When the killed vaccine is boostered, a secondary anamnestic response occurs.   
The duration of protection provided by vaccines tends to vary among studies reviewed.  
Cortese et al. (1998a) reported that cattle receiving a MLV BVD Type 1 vaccine induced 
antibodies to numerous BVD Type 1 and BVD Type 2 strains detectable through 18 months after 
vaccination.  In other studies, there was a decline in BVD antibody titers by 140 days after 
vaccination (Fulton et al., 1995; Fulton and Burge, 2000).  Revaccination at day 140 with either a 
killed or a MLV vaccine did induce increased antibodies in calves, especially those with low 
titers.  Fulton (2007) surmised that this rapid anamnestic response points out that, while antibody 
titers may decline or disappear, an improved immune response remains in effect. 
One must note that although some vaccines, directed at specific conserved proteins, such 
as toxoid vaccines, may completely prevent a particular disease, vaccines against complex 
disease agents that have multiple antigenic strains are unlikely to be capable of such levels of 
protection.  Respiratory vaccines are better viewed as disease modifiers than absolute 
preventative agents (Callan and Garry, 2002).      
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Vaccines are effective at not only reducing the individual’s own susceptibility, but also 
its ability to shed infectious agents to other calves (Frank et al., 1994; Frank et al., 2003).  
However, vaccines are not the only steps necessary to reducing spread of diseases.  Management 
practices that reduce pathogen introduction, exposure and transmission are important initial steps 
upon entry into the feedlot (Snowder et al., 2006).  Strategies that reduce stress placed upon the 
animal are also essential.  Newly received feedlot cattle typically face two problems that 
contribute to a high incidence of respiratory disease (Gaylean et al., 1999).  First, stress 
associated with weaning and transportation has a negative effect on the immune system (Blecha 
et al., 1984).  Secondly, this stress typically occurs at a time when the animal is exposed to a 
variety of infectious agents as a result of marketing/transportation/management practices 
(Gaylean et al., 1999).   
Stress 
Stress can have many negative effects on the health status of calves at feedlot entry.  
Stressors activate the hypothalamic pituitary adrenal axis (HPA).  This activation results in a 
physiologic change or adaption so that the animal can deal with the threat and have an “adaptive 
response” (Chrousos, 2000; Black, 2002; Elenkov and Chrousos, 2002; Bailey et al., 2003).  The 
transportation stress period can endure for as long as 15 d after arrival at the feedlot (Purdy et al., 
2000).  Numerous attempts have been made to reduce the impact of Bovine Respiratory Disease 
(BRD) through management practices, including preconditioning programs (Fulton et al., 2002).  
These preconditioning programs are designed to establish an effective immune response well in 
advance of any natural exposure.  In addition to vaccination, castration, and dehorning, these 
programs involve weaning and nutritional components.  Preconditioning programs usually 
require weaning of calves 30 to 45 d before shipment to allow the calf time to adjust to being 
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weaned and change in diet.  Cattle that originated from a known preconditioning program 
performed significantly better in the feedlot.  Preconditioned cattle have been shown to have 
significantly higher ADG, be more efficient, and have lower morbidity and mortality rates 
(Roeber and Umberger, 2002).  Pritchard and Mendez (1990) reported that perhaps behavior 
modification associated with the preshipment weaning procedure  is more important in 
determining intake by newly received cattle than is minor respiratory illness.   
Nutrition 
Nutrition can interact with stress by exasperating preweaning nutritional deficiencies and 
limiting nutrient supply through decreased feed intake (Cole, 1996).  Muggli et al. 1987, reported 
greater DMI for steer calves that were preconditioned for 30 d before shipment to a receiving 
facility as compared to steers that were weaned immediately before shipping.  Decreasing energy 
intake during the receiving period seems to affect ADG (Duff and Gaylean, 2007).  Calves fed 
low-quality, hay-based diets during receiving were unable to compensate for lost gain during 
subsequent finishing (Lofgreen, 1983; 1988).   
Deficiencies in minerals such as Cu and Zn can decrease an animal’s immune response, 
thereby increasing susceptibility to disease (Suttle and Jones, 1989).  Nonetheless, research on 
the effects of supplemental Cu and Zn on calf health has yielded conflicting results, and, the 
mechanisms by which these minerals work in conjunction with the immune response are not 
understood fully (Galyean et al., 1999; Salyer et al., 2004).  
Zinc. The earliest and most important clinical signs of zinc deficiency in ruminants, as in 
other species, are loss of appetite, parakeratosis and impaired wound healing (Miller et al., 
1965).  It is, therefore, possible that zinc deficiency weakens the first line of resistance to 
infection, i.e., the skin and other stratified epithelia, and also reduces the supply of major 
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nutrients for sustaining the increased metabolic rate following an infectious challenge.  
Nevertheless, losses from infections, when they occur, are probably secondary to the major 
debilitating effects of the deficiency (Suttle and Jones, 1989). 
Copper. The role of Cu in host defenses has been examined in several species.  Copper 
deficiency depresses lymphocyte responsiveness in rats (Bala et al., 1991), swine (Bala et al., 
1992), and sheep (Suttle and Jones, 1989).  Decreased neutrophil function has also been 
associated with copper deficiency (Xin et al., 1991).  Wright et al. (2000) evaluated the effects of 
Cu supplementation in a pre-weaning creep supplement on the performance and immune status 
of stressed calves.  The results suggest that pre-weaning Cu supplementation has minimal impact 
on performance, immune response or morbidity in stressed calves.  Research of supplementation 
with Cu before and during the receiving period at the feedlot also shows that supplementation 
does not impact performance or health characteristics of steers (Beck et al., 2001).  A review by 
Galyean et al. (1999) suggested that Cu deficiency, and, Cu deficiency coupled with high Mo 
and Fe, have inconsistent effects on immune function and furthermore, suggests that Cu 
deficiency may not affect specific immune function in calves.  Supplementation of Cu to animals 
with adequate status is not likely physiologically beneficial to the animal or economically 
beneficial to the producer (Wright et al., 2000).       
Selenium.  Effects of Se deficiency or supplemental Se on the humoral immune response 
in cattle has been variable (Swecker et al., 1989).  In stressed calves, supplemental dietary Se 
(0.1 mg of Se / kg of diet) resulted in higher serum IgM concentrations 17 d after inoculation 
with Pasturella haemolytica (Reffett et al., 1988).  In other stressed calves, though, Se injection 
had no effect on antibody titers to IBR virus or parainfluenza type-3 virus (Reffett et al., 1986).  
Droke and Loerch (1989) conducted five trials with steers new to the feedlot environment to see 
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the effects of injections with Se on performance, health, and antibody response.  Although 
increases in serum IgG titers to P. haemolytica were noted with the addition of Se at various 
times after vaccination, performance and health were not affected by treatments.    
Pre-feedlot diet composition - Assuming that pre-feedlot mineral status is adequate, 
type of diet prior to feedlot entry affects feedlot production and health.  Galyean et al. (1994) 
showed greater morbidity for calves preconditioned in drylot than calves on wheat pasture.  It 
was reported that the costs associated with morbidity are the most important determinants of 
profitability of feedlot cattle (Gardner et al., 1996).  Morbidity rates have been reported to 
account for approximately 8% of all production costs without consideration of losses due to 
reduced performance (Griffen et al., 1995). 
There is some evidence that preconditioning cattle is recognized as valuable by feedlot 
buyers.  Data from Superior Livestock auctions indicate that preconditioned cattle received a 
$3.33/cwt. premium compared with cattle not preconditioned.  A survey of feedlot managers 
indicated that managers were willing to offer a premium of $5.25/cwt. more than non-
preconditioned calves (Avent et al., 2002).  It was thought that cattle feeders knew more clearly 
than cow-calf producers the performance and profitability differences associated with 
preconditioned calves, but that they did not pay price premiums closely representing those 
expected benefits.  Results of the Avent et al. (2002) study suggest that feedlot managers do 
indeed know what performance differences exist.  However, these differences are not as 
pronounced as most cow/calf producers would expect.    
Economics of preconditioning - On an economic basis, preconditioning cattle on grass 
pasture is most favorable.  Branded commercial medicated feeds, fed ad libitum, can cost more 
than $40 per animal for a 21 d preconditioning period (St. Louis, 2003).  Avent et al. (2002) 
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reported that this cost could be as much as $60 per animal.  On a biological basis, several studies 
reported less sickness and greater gains by turning calves out on pasture after initial 
metaphylaxis, rather than feeding hay and supplements in a drylot (Galyean et al., 1994; Paisely 
et al., 2000).  There is evidence that buyers are willing to pay some premium for preconditioned 
calves, but by itself, not enough to cover preconditioning costs (Avent et al., 2002).   
Feedlot mortality may heavily impact the price premium a feedlot is willing to pay.  
Losses due to mortality can greatly affect the revenue of the pen.  Roeber and Umberger (2002) 
reported that percent mortality decreased by 10% in cattle having undergone a preconditioning 
program.  It was shown that ultimately mortality caused a decrease of $59.47 per animal when 
morbidity was classified as a class variable (Waggoner et al., 2007).  Most research does not 
include mortality in the calculation of net returns.  This, however, is not reflective of the 
industry.  Total net returns in the industry are calculated based on total expenses per pen minus 
the revenue of the pen.  This is then divided by the number of animals at the end of the finishing 
period to give net returns per head.  When mortality is calculated in, net returns per animal may 
be much closer to the premium levels offered by the feedlots. 
With the increase in value-based marketing feedlot operators have become increasingly 
interested in management practices that enhance the value of beef carcasses, while at the same 
time maintaining feed efficiency and reducing cost of gain (Roeber and Umberger, 2002).  This 
means that both cow-calf producers and feedlot operators have to become more in-tune to health 
and nutrition practices that have the potential to increase overall profitability.   
Conclusion 
 When evaluating the U.S. beef production system, a systems approach can be useful.  
With the systems approach, evaluation of the relationships of the components can be conducted 
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without losing sight of the whole.  In the end, beef producers want to produce a good quality, 
uniform product that is demanded by the consumer.  In order to do this, it is becoming 
imperative that all segments of the beef industry work together.  Changes in nutrition or health 
management programs at the cow/calf level can have great impacts on feedlot responses and 
carcass characteristics of the animal.  In addition, management practices at the feedlot level can 
affect the value received at the cow/calf level.  As consumers demand a higher quality product 
for a cheaper price, it is necessary that information flow both up and down the chain of the 
production setting.  All segments need to understand how their decisions affect the rest of the 
industry.  This literature review has attempted to highlight health and nutritional management 
inter-relationships that are known and have important implications in all production segments of 
the beef industry. 
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CHAPTER II 
EVALUATION OF THE ACUTE PHASE RESPONSE IN THE NEONATE BOVINE MODEL 
FOLLOWING VACCINATION AGAINST BOVINE RESPIRATORY DISEASE COMPLEX 
 
Introduction 
It is well established that bovine respiratory disease (BRD) causes economic losses in feedlot 
cattle (Duff and Galyean, 2007).  Thorough vaccination protocols have been indicated to 
enhance production against BRD related losses.  However, vaccination in itself is not protective; 
rather, the calf must develop a protective level of specific immunity to the target pathogens to 
confer protection in the face of a given level of challenge or exposure.  It is believed that if the 
calves have antibody titer formation prior to feedlot entry, it may help mitigate loses caused by 
the disease.  In order for antibody titer formation to occur, a cell-mediated immune response 
from vaccination needs to happen.  Due to management concerns, it may be best for calves to be 
vaccinated when all of the animals are already being penned and worked for other reasons.  As 
the number of times that the whole herd is gathered and worked is typically minimal, it may be 
necessary to vaccinate the calf at a very young age to ensure that it has been vaccinated prior to 
feedlot entry. 
There is evidence that it may be possible to vaccinate the calf at birth to against active 
pathogens (Zimmerman et al., 2006).  However, there are conflicting reports which suggest that: 
(1) maternal antibodies may neutralize the vaccine before it can cause a cell-mediated response; 
or (2) the neonate’s immune system is not developed enough to respond to a vaccine (Tizzard, 
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2000).  As the animal’s immune system is very complex, it could be that either of the reports are 
correct or that an understood piece is correct. 
There is evidence that cell-mediated immune responses may vary depending upon type of 
infection presented (Wu and Kurman, 1997).  Cell-mediated immune responses are regulated by 
T lymphocytes [T-helper (Th) lymphocytes and cytotoxic lymphocytes (CTLs)] in cooperation 
with antigen presenting cells (APCs) [monocytes (MCs) and dendritic cells (DCs)].  These cells 
all release cytokines that can influence one another’s synthesis and actions in the setting of an 
immuno-regulating cytokine network.  Cytokines in immune responses to infection are often 
classified as immune-stimulating Th1-type cytokines and immuno-inhibitory Th2-type cytokines 
(Bais et al., 2007).     
Classically, Th1 cytokines including IL-2 and IFN-γ, are involved in protection against 
intracellular pathogens; and TH2 cytokines, including IL-4 and IL-10, are required for protection 
against extracellular pathogens (Finkelman and Urban, 1992).  However, others have proposed 
that in vivo cytokine immune responses may not be only restricted to the response of discrete 
subsets but that different combinations of cytokine responses can be elicited by infectious agents 
(Kelso, 1995).  Canals et al. (1997) observed that infection with Ostertagia ostertagi reduced the 
percentage of T-cells, an increase in the percentage of B cells, and changes in cytokine mRNA 
expression characterized by decreased levels of IL-2 and increases in IL-4 and IL-10 
transcription.  Based on study results, they concluded that “together with the unrestricted 
cytokine secretion patterns of bovine T-cell clones, these results suggest that, in cattle, the Th1 
and Th2 paradigm may not be as clearly delineated as in the mouse model.”  Because of this it is 
likely necessary to measure cytokines associated with both Th1 and Th-2 lymphocytes to obtain 
a better understanding of how neonate calves respond to vaccination.   
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Very little information is available in the bovine model as to when these different cytokines 
may be expressed.  In the mouse model, Cruz et al. (2008) described the kinetics of cytokine 
secretion in response to an injection with snake venom.  They showed that a spike occurred 
within the first 24 h after injection in all of the cytokines measured.  However, depending upon 
the cytokine being measured, the release varied with time.  In the human model, in-vitro analysis 
of whole blood cultures demonstrated that cytokine release happened anywhere from 20 to 100 h 
after a mitogenic challenge (Bais et al., 2007).    
Because of the apparent role of cytokine release in the immunological cascade, knowledge of 
the cytokine response to vaccination in the neonate may provide insight into the temporal pattern 
of cytokine release in the bovine.  Additionally, characterization of cytokine release will allow 
identification of key sampling times in field studies, and enhance the ability to collect data from 
larger populations without the necessity of intensive serial blood collection. 
Therefore, the objectives of the present study were to: (1) determine cytokine profiles 
expressed as a result of vaccination, and (2) indentify optimal time points for measurement of 
cytokine secretion in neonatal Holstein calves.  
Materials and Methods 
Holstein steers (n = 8) were assigned at random to one of two vaccination treatment groups 
that included vaccination with either a modified-live virus [Arsenal 4.1® (ARS)] or a killed virus 
vaccine [ViraShield 6™(VIRA)] for bovine respiratory disease.  Treatment administration 
occurred within a week of animals’ births.  Blood samples and rectal temperature measurements 
were collected -1 h prior to treatment, hourly for the first 12 h after treatment administration and 
at h 18, 24, 30, 36, 48, 60 and 72.  Individual animal weights were recorded at h 0, and h 48.   
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Blood samples were drawn via jugular venipuncture into evacuated tubes and centrifuged at 
2,000 g, 4°C, for 20 minutes; serum was pipetted into 7mL polypropylene serum tubes and 
frozen at -80°C until they could be transported to the USDA-ARS Laboratory in Lubbock, TX.   
Samples were analyzed in duplicate within a single assay.  Serum concentrations of 
interleukin 4 (IL-4), interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-α) and interferon-
gamma (IFN-γ) were determined using a bovine specific ELISA plate kit as per the instructions 
of the manufacturer (R&D Systems, Minneapolis, MN).  Serum concentrations of interleukin 1 
beta (IL1-β) and interleukin 2 (IL-2) were analyzed using a commercially available ELISA kit 
specific for bovine IL1-β and IL-2 (R&D Systems, Minneapolis, MN).  Analyses were 
performed per manufacturer’s guidelines. 
Statistical analyses were performed in the mixed models procedures of SAS (SAS Inst. Inc., 
Cary, NC) as repeated measures with calf as the experimental unit.  Cytokine levels were 
expressed in pg/mL as difference from baseline (samples taken immediately prior to treatment 
administration).  Treatment, time, and treatment (time) were independent effects in the model.  
When results from the analysis produced P < 0.01, least squares means were separated for two-
tailed t-tests. 
Results and Discussion 
Cytokines are soluble protein mediators important for the orchestration of inflammatory 
responses (Romagnani, 2000; Cruz et al., 2008).  Cytokine secretions are the major determinants 
of the effectors’ functions of the cell-mediated (Th-1) or humoral responses (Abbas et al., 1993; 
Richeson et al., 2008).  The production of Th1 and Th2 cytokines is strictly controlled by 
complex feedback mechanisms (van Dissel et al., 1998; Taniguchi et al., 1999; Fasshauer et al., 
2003).  The Th1 cytokines such as IL-1, TNF-α and IFN-γ mobilize in the immune system cells 
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to proliferate and produce more cytokines creating an inflammatory cascade.  IL-4 and IL-10 are 
important in creating the Th2 response by dampening or inhibiting the inflammatory response 
(Chrousos, 2000; Agarwal and Marshall, 2001; Elenkov and Chrousos, 2002).  Th1 cytokines are 
primarily responsible for initiating a potent defense against exogenous pathogens.  In contrast, 
anti-inflammatory cytokines are crucial for down regulating the elevated inflammatory process 
and maintaining homeostasis for the correct functionality of VIRAl organs (Howard et al., 1993). 
A balanced ratio of pro- and anti-inflammatory cytokines is important for appropriate 
immune response (Cruz et al., 2008).  To determine the magnitude of the cytokine response 
caused by vaccination, we measured levels of cytokines in serum of neonatal calves.  The release 
(difference from baseline concentration) of IL-6 across sampling times was 5 times greater (P = 
0.03) in calves treated with VIRA than in those treated with ARS (Table 1).  Interleukin-6 is 
produced by a variety of cells types during infection, trauma, and immunological challenge.  The 
functional properties of IL-6 are extremely varied and this is reflected by the terminology 
originally used to describe the activities of this cytokine.  It has been described to have both pro- 
and anti-inflammatory effects, as well as being involved in a variety of immune responses (Cruz 
et al., 2008).  The results obtained in this study suggest that animals in the VIRA group produced 
significantly more IL-6 at 39.51 ± 8.16 pg/mL than those in the ARS group which produced 7.69 
± 8.16 pg/mL (as seen in Table 2). 
This study did not show an effect of vaccine type on IL-2 secretion.  However, it did show a 
significant influence of time on IL-2 serum concentrations (Table 1).  Serum concentrations 
peaked at h 60 but returned to baseline levels by 72 h (Figure 1).  Interluekin-2 is a cytokine 
whose immune function is not clearly understood.  It has been reported to have both an anti- 
inflammatory role as well as a pro-inflammatory role depending upon the study it is being 
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Table 1.  P-values of treatment, time, and treatment by time interactions of cytokine release 
(reported as change from baseline) in response to vaccination against bovine respiratory disease 
in neonatal calves. 
 Trt Time 
Trt x 
Time 
Residual 
variance 
Calf 
variance
IL1-b 0.10 <0.01 0.03 111.77 0.43
IL2 0.86 <0.01 0.98 128.1 0.84
IL4 0.14 0.08 0.89 366.94 0.58
IL6 0.03 0.10 0.17 2181.94 0.44
IFN-g 0.85 0.37 0.46 30366.00 0.86
TNF-a 0.18 0.07 0.54 256.11 0.67
 
1 Cytokines include: IL1-b (Interleukin 1 – β); IL2 (Interleukin 2); IL4 (Interleukin 4); 
IL6 (Interleukin 6); IFN-γ (Interferon gamma); and TNF-α (Tumor necrosis factor alpha). 
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Table 2.  Least squares means of cytokine secretion (reported as change from baseline) in 
response to vaccination against bovine respiratory disease in neonatal calves. 
 Vaccine  
Cytokine Arsenal 4.1 ViraShield 6 P-value 
IL1-b 6.81 ± 1.8 11.76 ± 1.8 0.10
IL2 -4.64 ± 3.7 -5.56 ± 3.7 0.86
IL4 12.29 ± 4 2.73 ± 4 0.14
IL6 7.69 ± 8.2 39.51 ± 8.2 0.03
IFN-g 24.81 ± 59 8.13 ± 59 0.85
TNF-a -3.91 ± 3.8 4.31 ± 3.8 0.18
 
1 Cytokines include: IL1-b (Interleukin 1 – β); IL2 (Interleukin 2); IL4 (Interleukin 4); 
IL6 (Interleukin 6); IFN-g (Interferon gamma); and TNF-a (Tumor necrosis factor alpha). 
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 evaluated in.  It is believed that IL-2 is a central mediator of immune responses and plays a role 
in homeostasis (Howard et al., 1993).   
Tumor necrosis factor-α is a pro-inflammatory cytokine which plays an important role in the 
immune response to infections and cancer and in the regulation of inflammation (Aderka, 1996).  
The present study shows that the elevation of serum concentrations of TNF-α occurs at h 24 and 
remains throughout the remainder of the study (Figure 2).  The main effect of vaccination was 
not significant in influencing TNF-α production (Table 1).  In this study, the serum 
concentrations of IFN-γ were similar for both groups (Table 1).  Response of IFN-γ was modest 
until h 60 at which it started to increase rapidly in some calves (Figure 1).  However, due to the 
larger standard error associated with the IFN-γ response, time did not play a statistically 
significant role.  IFN-γ is produced by a variety of cell types and plays a role in the early stages 
of host response to viruses and parasites.  IL-4 promotes humoral immunity by stimulating the 
growth and activation of mast cells and eosinophils, the differentiation of B cells into antibody 
secreting B cells, and B cell immunoglobulin switching to IgE (Abbas et al., 1993; Chrousos, 
2000; Marshal and Agarwal, 2000; Akdis et al., 2004).  The present study showed that type of 
vaccination did not alter IL-4 production (Figure 3).  There was a tendency for IL-4 to be 
influenced by time (Table 1).  The study also showed that vaccination has the ability to stimulate 
IL-4 production and allow IL-4 to exert its modulatory effect on host inflammatory response. 
The Th1 cytokine IL-1 is partially responsible for regulating TH2 cell development.  
However, it has been shown by Connor et al. (2005) that stress can inhibit the secretion and 
function of IL-1 while enhancing Th2 functions.  IL-1β responded differently to type of 
vaccination given (Table 1).  IL-1β peaked at h 5 in both treatment groups (Figure 4).  The 
present study also shows that response of IL-1β to vaccination was significantly higher for 
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Figure 1.  Effect of neonatal calf vaccination on interleukin 6 and interferon gamma levels. 1,2  
 
1 LS Means are reported as changes from baseline. 
2  Treatment x time interactions: IL-6 (P = 0.17); IFN-γ (P = 0.46). 
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Figure 2.  Effect of neonatal calf vaccination on interleukin 2 and tumor necrosis factor alpha 
levels. 1,2 
1 LS Means are reported as changes from baseline.   
2 Treatment x time interactions: IL-2 (P = 0.98); TNF-α (P = 0.54). 
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Figure 3.  Effect of neonatal calf vaccination on interleukin 1 beta and interleukin 4 levels. 1,2 
1 LS Means are reported as changes from baseline. 
2 Treatment x time interactions: IL1-β (P = 0.03); IL-4 (P = 0.89)
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Figure 4.  Interaction of vaccination and time on interleukin 1-β responses (change from 
baseline) in neonatal calves. 
* (P < 0.05) 
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 animals in the VIRA group at h 5, 7, 8, and 12.     
Some of the cells of innate immunity, notably macrophages and NK cells, secrete cytokines 
that activate phagocytes and stimulate the cellular reaction of innate immunity, called 
inflammation.  Inflammation consists of recruitment of leukocytes and proteins to eliminate the 
infectious agent.  This inflammation can injure normal tissues.  In the surrounding areas of 
inflammation, heat is produced.  In cases with systemic inflammation, whole body temperatures 
may increase.  Therefore, as a measure of inflammation we measured rectal temperatures of the 
calves.   
Rectal temperatures were not influenced (P = 0.83) by type of vaccination given. Mean 
rectal temperature was 39.5 °C.  Time did significantly alter temperature measurements (Figure 
5).  There was a tendency (P = 0.09) for vaccination treatment groups to have different 
temperatures over time (Figure 5).  Animals in the ARS group had less changes in body 
temperature from baseline after h 6.  At h 24 and h 48 animals in the ARS group returned to 
baseline.   
Temperature changes in the ARS group after h 6 correspond to changes in ambient 
temperature.   Results of this study suggest that it may be possible to get an accurate view of 
cytokine secretions without having to serially sample blood.  Due to cytokine and rectal 
temperature spikes around h 5, and again after h 48, we suggest that multiple measurements need 
to be taken to get a true picture of cytokine release.   
Conclusions 
While both vaccines stimulated cytokine production, the associated febrile response was not 
strongly correlated with the release of any specific cytokine.  Our results demonstrate that 
different vaccines have differential effects on the magnitude and timing of release of various 
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cytokines.  Understanding these differences and immunological sequelae to cytokine release may 
enhance development of vaccination strategies.
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Figure 5.  Change in rectal temperature from baseline (immediately prior to vaccine 
administration) of neonatal calves. 
* (P < 0.05) 
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CHAPTER III 
VACCINATION OF NEONATAL BEEF CALVES TO INDUCE A CELL-MEDIATED 
RESPONSE AGAINST BOVINE RESPIRATORY DISEASE COMPLEX 
 
Introduction 
One of the primary drawbacks of most preweaning vaccination programs is that calf 
immunity may not be fully activated prior to pathogen exposure during comingling.  A common 
recommendation is that ranchers vaccinate calves with some type of modified live or killed viral 
vaccine at weaning time.  At this same time, calves are loaded, shipped, commingled, and further 
transported to a feedyard or stocker operation.  The high incidence of infection in beef animals 
between the time of weaning and 9 months of age has prompted producers to begin vaccinating 
calves at a younger age (Rush et al., 2001).   
According to current dogma, animals with maternal antibodies will not benefit from 
vaccination.  It is believed that the maternal antibodies will “block” vaccine antigens before they 
elicit a response from the calf’s own immune system.  As part of the parturition process calves 
produce high levels of cortisol that remain elevated for the first week of life.  The cumulative 
effect of these hormones and maternal antibodies is to suppress immune responses and direct the 
immune response away from TH1 responses.  These also promote short-term TH2 immune 
responses, which utilize maternal antibodies but create no memory cells (Chase et al., 2008).  
However, there is developing research that indicates that neonatal calves can be immunologically 
primed by vaccinations even in the presence of maternal antibodies.  
In 2008, Zimmerman et al. published a report showing that vaccinating calves at 5 weeks of 
age with a modified-live virus (MLV) Bovine Viral Diarrhea (BRD) vaccine induced a strong 
protective immune response in these young calves, even when plasma concentrations of maternal 
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antibodies were high. Similar results have been observed in calves that received Infectious 
Bovine Rhinotracheitis (IBR) and Bovine Viral Diarrhea (BVD) vaccines while still receiving 
passive maternal antibodies to these viruses (Brar et al., 1978).  Brar et al. (1978) showed that 
while passive immunity initially prevented a detectable response, priming for a secondary 
response did occur.  Calves that were vaccinated a second time, when maternal antibodies were 
no longer present, developed a higher antibody titer more rapidly than those that had not received 
a priming vaccination.  
 Another research trial also showed that the bovine neonate can mount a vigorous, adult 
like cell-mediated response when vaccinated at an early age.  Researchers vaccinated calves with 
Mycobacterium bovis bacillus Calmette-Guerin at 1 week and 7 weeks of age and found that 
early vaccination of calves was associated with a Th1-like response to the antigen comparable to 
the response of adult cattle sensitized in the same manner (Nonnecke et al., 2004).  However, 
they also showed with the BRSV model, as Ellis et al. (1996) did earlier, that although the calves 
developed adult-like cell-mediated immune responses in vivo and ex vivo, their humoral 
responses (characterized by serum antibody) were minimal relative to responses of vaccinated 
adult cattle.  These results show promise that a cell mediated response can be elicited from a 
viral respiratory vaccine given within a week of birth.  However, additional questions arise.   
The primary question is whether or not a vaccination within a week of birth would 
effectively prime the calf’s immune system to the level necessary for the animal to mount an 
adequate response when faced with the stressors of comingling and weaning several months 
later.  Because many producers tag and/or weigh calves within a week of birth, this would 
provide an initial opportunity to administer a product, with a booster vaccination given at more 
traditional time points (such as branding), prior to exposure of the calf to the pathogen.  
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Therefore, the calf would have greater cellular immunity before it was shipped, reducing the 
need for a holding or preconditioning period. 
The second question, which has not been adequately addressed in the literature, is whether 
or not a killed virus vaccine is as effective as a modified live virus vaccine in promoting a strong 
cell-mediated response when given to neonatal calves.  This question has great importance in 
application, as producers may have reservations about giving a live virus vaccine to calves 
suckling pregnant cows, and few products are currently labeled for such use. 
Therefore the objectives of this study were to: (1) determine if a cell-mediated response to 
the bovine respiratory disease complex can be initiated in the presence of maternal antibodies, 
(2) ascertain if early stimulation of a cell-mediated response can illicit greater lifetime immunity 
in the beef animal, and (3) discover the effectiveness of a modified live virus vaccine versus a 
killed vaccine in cell-mediated responses when administered to the neonatal calf. 
Materials and Methods 
Fifty-two beef calves from Brangus dams and a Braunvieh sire were used for this study.  
Dams were either 5 or 6 years of age.  Calves were randomly assigned at birth to one of five 
treatment groups receiving either ViraShield®6 (Killed; K) or Arsenal 4.1™ (Live; L). 
ViraShield®6 is a killed viral vaccine to Bovine Viral Diarrhea virus (BVD) type 1, BVD type 2, 
Infectious Bovine Rhinotracheitis (IBR), Parainfluenza-3 (PI3) and Bovine Respiratory Syncytial 
Virus (BRSV). Arsenal 4.1™ is a modified-live virus (MLV) vaccine to BVD Type 1, BVD 
Type 2, IBR, PI3, and BRSV.  Treatment groups included: Control (CONl); Killed at d 0 
followed by Killed at d 100 (KK); Killed at d 0 followed by Live at d 100 (KL); Killed at d 0 
followed by Killed at d 150 (KNK); Live at d 0 followed by Killed at d 100 (LK) (shown in 
Table 3).   
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Both steers and heifers were used for this study (Table 4).  Steer calves were castrated by 
knife after the 6 h blood draw at birth.  All calves were worked within 3 d of birth.  The calf birth 
date distribution is shown in Figure 6.   
Blood samples were collected on d 0 of the trial prior to treatment application at h 0 for 
cytokine, serum neutralizing antibody titer to BVD Type 1 and IBR, total serum protein, and 
serum Immunoglobulin G (IgG) analyses.  Day 100 and subsequent time measurements were 
determined by taking median date of calf birth and adding 100 days.   
Body temperature was measured rectally at each collection time.  Collection times included: 
d 0 (hours 0, 6, 48), d 21 (hour 0), d 100 (hours 0, 6, 48), d 158 (hours 0, 6, 48), d 200 (hour 0), 
and d 250 (hour 0).  For all time points h 0 was at 0830 hours.   
Body weights were measure on each day that sampling occurred.  Blood samples were 
collected for cytokine analyses at d 0, d 100, d 158.  Collection on each of the three days 
occurred at hours  0, 6, and 48.   Blood samples were collected for serum  neutralizing antibody 
titers to IBR and BVD Type 1 analyses on d 0, d 21, d 100, d 158, d 200, and d 250  
at h 0.    
Blood samples were drawn via jugular venipuncture into evacuated tubes, allowed to clot on 
ice, and centrifuged at 2,000 g, 4°C, for 20 minutes. Serum was divided into 3, 2 ml aliquots and 
pipetted into storage vials.  One aliquot was frozen at -20 °C and sent to Texas Veterinary 
Medical Diagnostic Laboratory (TVMDL, Amarillo, TX) for quantification of serum neutralizing 
antibody titers to BVD Type 1, and IBR.  A second aliquot was frozen at -80°C until it could be 
transported to the USDA-ARS Research Laboratory in Lubbock, TX.   
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IgG and total protein samples were handled in the same manner as the cytokine samples 
through the freezing process.  IgG analysis was conducted at Texas A&M University using a 
sandwich ELISA specific to bovine IgG.  Total serum protein levels were determined using a 
commercially available bicinchoninic acid protein kit (BCA1, Sigma Aldrich, Saint Louis, MO).  
Analyses were conducted according to manufacturer directions. 
For cytokine analyses, samples were analyzed in duplicate within a single assay.  Serum 
concentrations of interleukin 4 (IL-4), interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-α) 
and interferon-gamma (IFN-γ) were determined using a bovine specific ELISA plate kit as per 
manufacturer instructions (R&D Systems, Minneapolis, MN).  Serum concentrations of 
interleukin 1 beta (IL1-β) and interleukin 2 (IL-2) were analyzed using a commercially available 
ELISA kit specific for bovine IL1-β and IL-2 (R&D Systems, Minneapolis, MN).  Analyses 
were performed per manufacturer’s guidelines. 
A group of 5 heifers from another herd on the ranch were used for a as a positive control.  
Cytokine data were not measured on these calves.  All other data were collected on the ranch 
calves.  Ranch calf treatment included receiving a modified live virus vaccine at d 100 and at d 
150.   
Statistical analyses were performed using the mixed models procedures of SAS (SAS Inst. 
Inc., Cary, NC).  Rectal temperatures, body weight, and serum neutralizing antibody titers were 
analyzed as repeated measures with day as the repeated term.  Cytokine data were analyzed first 
as repeated measures with hour nested within day as the repeated term.  When the day by 
treatment interaction was significant, cytokine data were then analyzed with hour as the repeated 
term and the “by day” statement added to the model. 
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Table 3.  Treatment distribution of calves receiving either a modified live virus vaccine or killed 
vaccine at birth to bovine viral diarrhea and infectious bovine rhinotracheitis. 
 
    Birth   d 100  d 158  d 200  d 250   
 
Ranch   N  K  L  L  - 
 
Neg Control  N  N  K  L  - 
 
K / K   K  K  N  L  - 
 
K / L   K  L  N  L  - 
 
K/N/K   K  N  K  L  - 
 
L / K   L  K  N  L  - 
 
 
* Day 200 Vaccination is to guarantee that all animals fulfill the Caprock Feeders criteria. 
** Treatments groups include: N (None); K (killed vaccine); L (modified live virus vaccine) 
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Table 4.  Distribution of treatments by gender (numbers of animals). 
 
 
  Treatment 
  Control K-N-K K-L K-K L-K 
Steer 6 5 5 5 5 
G
en
de
r 
Heifer 4 5 6 5 5 
 
 
 
 
* Treatments include Con (Control – No vaccine given); KK (Killed vaccine given at birth and at 
day 100); KL (Killed vaccine given at birth and a Modified-live virus vaccine given at day 
100); KNK (Killed vaccine given at birth and at day 158); LK (Modified-live virus vaccine 
given at day 0 and a killed vaccine given at day 100). 
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Figure 6.  Birth date distribution of animals by week. 
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Serum-neutralizing antibody titer count data were transformed to log2 prior to analyses, and the 
results are expressed in this form (i.e., the values represent x in the form 2x; data were not back-
transformed for presentation). Average daily gain was computed as the average weight gain (kg) 
divided by time between weight collections (d) for specific time periods.  Cytokines were 
expressed in pg/mL as the difference from baseline within collection day.  Hour 0 measurements 
within the day were used as baseline. 
Level of significance was set at P < 0.05.  If effects were declared significant, Fisher’s Least 
Significant Difference (PDIFF) option in the LSMEANS statement of SAS (SAS Institute, Cary, 
NC) was used to separate means.  PROC CORR was used to examine correlations among all 
variables on and between hour within day.  Only significant (P < 0.01) correlations are reported. 
Results and Discussion 
Body temperature.  No treatment by time interactions were observed for rectal 
temperature.  Differences due to day were observed, and mean rectal temperature across 
treatment group is reported in Figure 7.  Changes in rectal temperature closely followed changes 
in ambient temperature experienced at time of sample collection. 
Immunoglobulin G.  Serum IgG levels collected shortly after birth represent passive 
transfer from the dam, and thus reflect quantity and quality of colostral intake by calves (Musgli 
et al., 1987).  All calves had high circulating blood serum IgG levels that ranged from 7.09 to 
7.92 g/L with a coefficient of variation of 5.2%.  Arthington et al. (2000) reported that colostrum 
deficient calves had circulating IgG levels in serum of less than 1 g/L and that calves 
supplemented with high quality colostrum had up to 12 g/L IgG.  
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Figure 7.  Mean rectal temperatures (°C) in groups of calves vaccinated neonatally against BVD 
and IBR.   Temperature different (P<0.01) from one time period to the next except for the 
period between December 2007 and March 2008.  
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Body weight.  Body weight increased over time (P < 0.01, Figure 8) as expected in young 
growing animals.  Treatment did not interact with day to alter weight gains of the calves (P = 
0.69).  Day was significant, and mean weights across treatment are shown in Figure 3.  In 
addition, the main effect of treatment was also significant for weight gain (Table 5).  Calves in 
the control group had the highest (P < 0.05) weaning weights of the calves in this study at 309.39 
kg.  Animals that received the MLV vaccine at birth or the animals that received the killed 
vaccine at birth and day 158 were intermediate to the control and the KK and KL treatment 
groups.  Average daily gains were also affected by the type of treatment given (P < 0.01).  
Animals receiving the control treatment had the highest average daily gains while animals 
receiving the KNK treatment had intermediate average daily gains to that of the other groups.  
Animals in the KL group had the lowest (P < 0.05) average daily gains at 1.49 kg/d. 
Serum neutralizing antibody titers.  Serum neutralizing antibody titers against both BVD 
Type 1 and IBR varied over time (P < 0.01, Figure 3).  Titer levels decreased over the period of 
the trial.  However, at d 250, titer levels to BVD Type 1 increased compared to d 200 levels (P < 
0.01).  The significant day effect is consistent with previous reports of the contributions of 
maternal antibodies to resulting antibody levels of the calf.  Brar et al. (1978) reported that 
antibody levels of calves decreased at a steady rate throughout the first 175 d of life.  After of 
which, depending upon the vaccination strategy, the calves started producing titers of their own.   
Longevity of antibody production due to passively acquired antibodies is highly dependent 
upon milk quality and yield given by the cow.  Because of the high levels of IgG measured at the 
onset of this trial and the age of the dam, it is our belief that these calves received more than an 
adequate amount of passively transferred antibodies.  Therefore, we did not expect to see much 
of an increase in titer levels prior to 175 d of life.  After of which, we did hope to find that a  
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Figure 8.  Weight gain and antibody titer levels of calves vaccinated with either a modified-live 
virus vaccine or a killed virus vaccine to bovine viral diarrhea virus (BVD) and infectious 
bovine rhinotracheitis (IBR).    
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Table 5.  Least squares means for production data and antibody titer levels for calves receiving a neonatal vaccination to bovine 
respiratory disease. 
 
 
Con KK KL KNK LK SE P-Value
BVD Type 1 3.67 b 3.98 ab 3.95 ab 3.38 b 4.72 a 0.28 0.02
IBR 3.89 a 3.08 b 3.20 b 3.23 b 3.49 ab 0.18 <0.01
Weaning Weight (kg) 309.39 a 285.38 b 282.85 b 290.18 ab 300.02 ab 8.31 <0.01
ADG (kg/day) 1.64 a 1.50 b 1.49 b 1.55 ab 1.53 b 0.03 0.02
Temp (°C) 39.60 abc 39.51 c 39.75 ab 39.55 bc 39.67 ab 0.07 0.03
Treatments
 
 
 
* Treatments include Con (Control – No vaccine given); KK (Killed vaccine given at birth and at day 100); KL (Killed vaccine given 
at birth and a Modified-live virus vaccine given at day 100); KNK (Killed vaccine given at birth and at day 158); LK (Modified-
live virus vaccine given at day 0 and a killed vaccine given at day 100). 
ab  Different superscripts within a row differ (P < 0.05). 
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priming response had occurred and the calf’s own immune system would start creating antibody 
titers that exceeded that of the controls.  For the overall day effect, there was not a significant 
increase in titers to BVD at day 250, but it appeared that an upward trend could have been 
beginning. Titer levels for IBR did not change from d 200 to d 250. 
Titers of serum neutralizing antibody against BVD Type 1 were measured at birth and 
throughout d 250 of the calf’s life (Table 6).  Animals vaccinated with the MLV at birth created 
significantly more antibody titers (4.72log2) than animals in the control group (3.67log2) or animals 
that received the killed vaccine at birth and at day 158 (KNK).  Animals in the KK and KL 
groups were intermediate to the other treatment groups. 
Animals in the control group had the highest (P < 0.05) IBR titer levels (3.89log2).  Calves 
that received the MLV vaccine at birth (3.49log2) were intermediate to all other treatment groups 
in this study for IBR titer levels.  Animals in the KK, KL, and KNK treatment groups were not 
significantly different from each other in their production of serum neutralizing antibody titers to 
IBR. 
Because animals in the control group had the highest antibody titer levels to IBR, we re-
examined the raw data to see if we could find a time in which calves in this trial were exposed to 
IBR.  We were not able to find any point(s) in which it seemed they were exposed.  Titer levels 
at birth were consistent with that of calves that received antibodies through passive transfer.  The 
titer levels then dropped throughout the subsequent life of the animal with no apparent spikes 
that would have indicated a possible exposure.  One possible explanation for the observed results 
might be by shedding of vaccine strains from calves vaccinated with the MLV.  As virus can be 
transferred from one animal to the other through mucus or direct contact, it is hypothesized that  
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Table 6.  P-values for cytokines of neonatal calves analyzed for the main effects of treatment 
(Trt) and day and the interaction of treatment and day. 
 
 
 
 Trt Day Hour 
Trt x 
Day 
IL-1 
Beta 0.10 0.07 0.12 0.07
IL-2 0.72 0.12 <0.01 0.91
IL-4 0.56 0.38 <0.01 0.55
IL-6 <0.01 <0.01 <0.01 <0.01
IFN-g <0.01 <0.01 0.01 <0.01
TNF-a 0.75 0.08 0.35 0.11
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it is possible for an unvaccinated animal to become exposed after coming in contact with a 
vaccinated animal. 
Cytokine analysis.  Serum samples were taken for cytokine analysis at 0, 6, 48 h for days 0, 
100, and 158 of the trial.  A treatment by day interaction occurred for most of the cytokines 
sampled.  Figures 9 - 27 represent the treatment by hour interactions within day.  We found only 
one treatment by hour interaction within day (Table 7).  We believe that this interaction occurred 
because the IL-4 response of animals in the LK group spiked at h 48 on day 100.  This spike 
caused a shift in slopes of the lines that differed from the slopes of the lines at h 6.  In addition, 
we also found a spike in the LK group of IL-4 levels at h 48 on d 158.  While this was not 
significant, there was a trend for the IL-4 to be increased by h 48.  When looking at the overall 
plot of IL4 by day (Figure 28), it can be seen that animals in the LK group had the highest IL-4 
levels on day 100 and 158.   
We also observed a trend in IL-6 that is in agreement with our preliminary trial with 
Holstein calves where IL-6 spiked at h 6 and fell back again at h 48.  This hour effect was 
significant at the P < 0.01 level for both day 100 and 158, but not at day 0 (P = 0.13).  No other 
treatment by hour (within day) interactions were found for any of the investigated cytokines.  
The data are presented in Figures 9 through 26 for a representation of the trends.   
IFN-g levels were tested in circulating serum after each vaccination was given.  When 
looking at d 0 it can be seen that IFN-γ levels increased in the LK, KNK, and KK groups at both 
h 6 and 48 over that of the control group.  When moving to d 100, it can be seen that animals in 
the LK, KK, and KL groups had higher (P < 0.01) cytokine levels at h 48 for IFN-γ over that of 
animals in the control group.  It is not surprising that animals in the KNK group had similar IFN-
γ levels to that of the control at d 100 as the KNK group did not receive a vaccination at day 100.  
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When moving out to d 158, we observed that animals in the KNK group had higher IFN-γ levels 
than animal in the other groups at h 48.  This can be explained by the fact that only animals in 
the KNK group received a vaccination on d 158. 
Correlations. Cytokine levels were not correlated with antibody titers to BVD or IBR (P > 
0.05).  We were able to observe correlations among cytokines within hour on d 0.  For d 0, 6 h 
we found that IL1-β was correlated (P < 0.01) to IL-2 at a moderate level.  IL4 was significantly 
correlated to IFN-γ at a strong level.  TNF-α was significantly correlated to IL-6 and IFN-γ at 
moderate levels.   
At d 0, h 48 we found a significant correlation among IL-2 and IL-6 (r = 0.52).  In addition, 
a strong correlation (r = 0.81) was found between IL-4 and IFN-γ.  While not as strong as the 
correlation at h 6, this correlation did remain throughout h 48.   
There were several correlations among cytokines on d 158, and mainly existed within hour.  
Cytokine levels on the same day but different hours were not strongly correlated.  We did find 
that on d 158, h 6 IL1-β was significantly correlated to TNF-α at a coefficient of 0.68.  IFN-γ 
was also significantly correlated to IL-6 (r = 0.45). 
On day 158, h 48 we found that several cytokines were significantly correlated to each 
other.  IL-6 and IL1-β had a correlation coefficient of 0.72 while IL-6 and IL-2 had a correlation 
of 0.88.  As mentioned above, we also found a correlation between IL-6 and IL-2 on d 0, h 48 
that was not as strong at the correlation on day 158.   TNF-α was correlated to IL1-β, IL-2, and 
IL-6 with coefficents of 0.53, 0.66, and 0.83, respectively.  We did not find correlations among 
cytokines across different days.
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Table 7.  P-values for cytokines of neonatal calves, analyzed with hour as a repeated measure, by day.  
 
 
 Day 0  Day 100 Day 158 
 Treatment Hour Interaction Treatment Hour Interaction Treatment Hour Interaction 
IL1-B 0.06 0.19 0.78 0.03 0.39 0.57 0.62 0.17 0.47 
IL2 0.76 <0.01 0.97 0.46 0.27 0.51 0.64 0.65 0.32 
IL4 0.58 0.04 0.95 0.09 <0.01 0.03 0.17 0.10 0.10 
IL6 <0.01 0.13 0.17 0.06 0.01 0.42 0.32 <0.01 0.28 
TNF-a 0.39 0.26 0.86 0.36 0.77 0.29 0.17 <0.01 0.48 
IFN-g 0.31 0.61 0.86 0.07 <0.01 0.27 <0.01 0.08 0.31 
 
 
* P-values given here because treatment by day interaction was significant for the cytokine models.  All cytokines were reported as 
change from baseline measurement (h 0) within day. 
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Figure 9.  Interleukin 1 beta levels (represented as change from hour 0) at day 0 of neonatal 
calves vaccinated within three days of birth. 
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Figure 10.  Interleukin 1 beta levels (represented as change from hour 0) at day 100 of neonatal 
calves vaccinated within three days of birth. 
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Figure 11.  Interleukin 1 beta levels (represented as change from hour 0) at day 158 of neonatal 
calves vaccinated within three days of birth. 
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Figure 12.  Interleukin 2 levels (represented as change from hour 0) at day 0 of neonatal calves 
vaccinated within three days of birth. 
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Figure 13.  Interleukin 2 levels (represented as change from hour 0) at day 100 of neonatal 
calves vaccinated within three days of birth. 
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Figure 14.  Interleukin 2 levels (represented as change from hour 0) at day 158 of neonatal 
calves vaccinated within three days of birth. 
 
 
 
 
59
 
 
 
 
Figure 15.  Interleukin 4 levels (represented as change from hour 0) at day 0 of neonatal calves 
vaccinated within three days of birth. 
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Figure 16.  Interleukin 4 levels (represented as change from hour 0) at day 100 of neonatal 
calves vaccinated within three days of birth. 
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Figure 17.  Interleukin 4 levels (represented as change from hour 0) at day 158 of neonatal 
calves vaccinated within three days of birth. 
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Figure 18.  Interleukin 6 levels (represented as change from hour 0) at day 0 of neonatal calves 
vaccinated within three days of birth. 
 
 
 
 
63
 
 
 
 
Figure 19.  Interleukin 6 levels (represented as change from hour 0) at day 100 of neonatal 
calves vaccinated within three days of birth. 
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Figure 20.  Interleukin 6 levels (represented as change from hour 0) at day 158 of neonatal 
calves vaccinated within three days of birth. 
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Figure 21.  Interferon-gamma levels (represented as change from hour 0) at day 0 of neonatal 
calves vaccinated within three days of birth. 
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Figure 22.  Interferon-gamma levels (represented as change from hour 0) at day 100 of neonatal 
calves vaccinated within three days of birth. 
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Figure 23.  Interferon-gamma levels (represented as change from hour 0) at day 158 of neonatal 
calves vaccinated within three days of birth. 
 
 
 
 
68
 
 
 
 
Figure 24.  Tumor necrosis factor-alpha levels (represented as change from hour 0) at day 0 of 
neonatal calves vaccinated within three days of birth. 
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Figure 25.  Tumor necrosis factor-alpha levels (represented as change from hour 0) at day 100 of 
neonatal calves vaccinated within three days of birth. 
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Figure 26.  Tumor necrosis factor-alpha levels (represented as change from hour 0) at day 158 of 
neonatal calves vaccinated within three days of birth. 
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Table 8.  P-values for cytokines of neonatal calves analyzed for the main effects of treatment 
and day and the interaction of treatment and day when treatments listed by type of vaccine given 
at birth. 
 
 
 
 Trt Day Hour Trt x Day 
IL-1 
Beta 0.19 0.02 0.04 <0.01
IL-2 0.71 <0.01 <0.01 0.71
IL-4 0.08 <0.01 0.22 0.58
IL-6 0.06 <0.01 <0.01 0.32
IFN-g 0.35 <0.01 0.48 0.07
TNF-a 0.34 0.38 0.45 0.25
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Table 9.  Least squares means and standard errors of treatment categories as represented by type 
of vaccine given at birth to beef calves. 
 
 
 Con   Kill   Live   SE 
IL-4 8.07 ab 7.01 b 13.02 a 3
IL-6 7.23 b 17.54 a 13.17 ab 3.77
BVD Type 1 3.67 b 3.77 b 4.72 a 0.28
IBR 3.9 a 3.17 c 3.49 b 0.22
Weight (kg) 162.98 a 148.69 b 154.3 ab 4.3
ADG 
(kg/day) 1.75 a 1.6 b 1.62 b 0.04
 
 
* Main effect of treatment was significant (P < 0.01).  Treatments include Con (control – nothing 
given at birth); Kill (killed vaccine given at birth); Live (modified-live virus vaccine given at 
birth). 
ab Different superscripts within row different (P < 0.01). 
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Figure 27.  Changes in least squares means for interleukin-4 circulating in serum from baseline 
(hour 0) of neonatal calves given a vaccine to the bovine respiratory disease complex. 
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Figure 28.  Least squares means for serum neutralizing antibody titers to bovine viral diarrhea 
virus type 1. 
* Significant (P < 0.01) differences exist between treatments within day 
** All animals were re-vaccinated with a modified live virus vaccine at day 200 to meet 
contractual specifications with the feedlot. 
*** Treatments include Con (Control – No vaccine given); KK (Killed vaccine given at birth and 
at day 100); KL (Killed vaccine given at birth and a Modified-live virus vaccine given at day 
100); KNK (Killed vaccine given at birth and at day 158); LK (Modified-live virus vaccine given 
at day 0 and a killed vaccine given at day 100); Ranch (Killed vaccine given at day 100 and a 
live vaccine given at day 158) 
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Pooled analysis.  We also decided to look at the data based only on the first shot received in 
an attempt  to determine if first shot given strongly influenced outcomes.   Therefore, animals in 
the LK group will be listed as Live.  Animals in the KK, KL, and KNK groups will be grouped 
as Killed.  The control animals will remain control.  These data was only analyzed for the 
production effects (not cytokine effects).  
Again, we only observed significant (P < 0.01) main effects (Table 6).  No treatment by 
time interaction occurred.  Least squares means of the pooled treatment categories are shown in 
Table 5.  As with the other analysis, we found that animals receiving the modified-live virus 
vaccines had significantly higher IL-4 and antibody titers to BVD.  
In 2006, Zimmerman et al. demonstrated that a single dose of a MLV vaccine containing 
BVDV administered at 4 to 5 weeks of age stimulated a strong protective response in calves in 
the face of high concentrations of maternal antibodies.  Our results also indicate that a MLV 
vaccine can stimulate a strong immune response.  However, since we vaccinated within three 
days of birth, we can say that the MLV vaccine can induce a priming response in the neonate.   
Based on the IL-4 results and the serum neutralizing titer levels to BVD Type 1, it can be 
concluded that a priming and secondary response did occur in animals that received a modified-
live virus vaccine at birth and a killed vaccine at d 100.  The IL-4 results indicate that 
proliferation of B-cells occurred in the LK group.   
A study by Endsley et al. (2003) showed that a priming effect due to vaccination with a 
modified-live virus vaccine occurred in calves with high levels of maternal antibodies present.  
They went on to indicate that the cellular priming effect occurred while the BVD humoral 
immune response was blocked.  Calves vaccinated with MLV BVD vaccine at 7 weeks of age 
developed BVD-specific CD4+ and γδ-T-cell responses, whereas calves vaccinated with an 
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inactivated vaccine at the same time did not develop BVD-specific T-cell responses.  While 
these results are consistent with our findings, our studies did differ in the serum-neutralizing 
antibody response to BVD when the calves were given a killed vaccine.  They found that calves 
vaccinated with either a MLV or killed BVD vaccine in the face of circulating maternal 
antibodies developed a memory antibody response to BVD upon subsequent vaccination.  
However, in this study, we found that serum neutralizing antibody titers to BVD Type 1 and IBR 
declined after infection.  As we did not challenge the calves, we cannot infer as to protection 
levels of the calves.  However, in studies by Ridpath et al. (2003) and Zimmerman et al. (2006) it 
was shown that antibody serum titer levels to BVD continued to decrease after vaccination, and 
only increased after challenge with virulent BVD. 
Serum neutralizing titer levels to BVD Type 1 did not indicate that we had an anamnestic 
response when all calves were vaccinated at d 200 with a MLV to meet contractual demands.  
Figure 23 shows the least squares means of the calves prior to and after receipt of this MLV 
vaccine.  Calves in the Ranch group (n = 5), following traditional ranch practices of this 
producer, had significantly higher antibody titer levels to BVD than all other treatment groups at 
4.98log2 on d 250.  These results do not agree with those of Cortese et al. (1998b) who reported 
that vaccinating once with a MLV vaccine to BVD Type 1 had increasing or stable 
concentrations of serum antibodies for up to 18 months after vaccination.  They, however, used 
calves that were older (greater than 6 months of age) and therefore had more advanced immune 
systems.   
Calves in the Ranch group had similar IBR titers to that of the Control calves; thus 
indicating further that maternal transfer played a larger role in antibody production to IBR than 
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did vaccination.  Cows in this herd were vaccinated yearly (in the fall of the year) with a 
modified live virus vaccine to IBR, BVD Type 1 and BVD Type 2. 
While we were able to show a priming response with the cytokines, we also believe that we 
were able to show that we had elicited an immune response not indicated by antibody titer levels.  
Cytokine results indicate that at h48, animals receiving a vaccination would increase circulating 
levels of IFN-γ.  As the animals were vaccinated with a viral vaccine, it can be understood why 
an antiviral cytokine would be secreted in their presence.   
In addition, on each day that cytokines were measured, we saw an increase in IL-6 at h 6.  
Abbas et al. (2005) reported that some of the selected functions of IL-6 are antigen specific 
immune responses, inflammatory responses, B cell differentiation and T cell activation.  We 
cannot differentiate with our results, which of these responses were induced by inoculation with 
the vaccine; we were, however, able to show that IL-6 levels were increased 6 h post 
vaccination.      
Conclusions 
As beef calves are often vaccinated at time of branding, when calves are 1 to 3 months of 
age (Zimmerman et. al., 2006), these results become very important to the cattle industry. We 
have documented that vaccination at birth with a MLV vaccine can protect calves from the 
perinatal period to early adolescence.  We were able to induce a cytokine response in the face of 
maternal antibodies.   
This project showed that at this early age, average daily gains and subsequent weights may 
be reduced below that of control animals.  However, as we had no signs of clinical infection, 
these results must be taken with the idea in mind that vaccination is an insurance measure to 
prevent disease outbreak.  And therefore, while animals may not gain as much as those not 
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receiving a vaccine, they also are not protected against disease and the losses associated with the 
disease. 
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CHAPTER IV 
EFFECTS OF FEED INTAKE AND CARCASS CHARACTERISTICS IN FEEDER CATTLE 
VACCINATED WITH ARSENAL 4.1® OR VISTA™ 5 SQ 
 
Introduction 
  Respiratory disease is one of the largest health problems associated with post weaning 
stages of beef production (NAHMS, 1997).  Morbidity associated with the Bovine Respiratory 
Disease (BRD) complex reduces performance, production efficiency, and product quality; 
increases input costs and mortality; and results in a value loss of between $90 and $150 per case 
(Texas A&M University, Ranch to Rail, unpublished data). A variety of bacterial and viral 
infectious agents play a role in the etiology of BRD. Viral pathogens are considered primary 
insults to the immune system that result in progressive colonization and infection with 
pneumonic bacteria. Viral agents isolated from animals with BRD include infectious bovine 
rhinotracheitis virus (IBR), bovine respiratory syncytial virus (BRSV), bovine viral diarrhea 
virus (BVD), and parainfluenza 3 virus (PI3).  The large per case cost of BRD provides 
motivation for producers to utilize prophylaxis when available, and the initiative role of viral 
agents in the disease complex suggests that effective immunization against these pathogens 
creates value through risk reduction when and if the immunization process is effective and does 
not present secondary complications. 
Live-virus vaccines are available which produce high and sustained immunological 
responses to these antigens (Vaughn and Sweiger, 1997). However, concern exists that live-virus 
vaccines may induce a large febrile response.  While this response is beneficial to the animal at 
the cellular level (cytokines mediating an acute phase response), it results in increased energy 
expenditure, decreased feed consumption, and thus decreased weight gains.  Because different 
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modified live virus vaccine products contain different antigenic strains, it may be possible for 
calves to have differential febrile and performance responses to those vaccines. 
The objective of this trial was to evaluate immunological and production responses by 
weaned beef calves to two commercially available vaccines [Arsenal 4.1® (ARS) (modified-live 
virus vaccine and Vista™ 5 SQ (VISTA) (killed vaccine). Titer formation, body temperature, fat 
deposition, feed consumption, and subsequent carcass composition measurements of beef cattle 
receiving these vaccines were measured as an indication of the animal’s response to the vaccine. 
Materials and Methods 
  Animals.  One hundred seven Angus-Nellore crossbred steers of known origin and no 
prior exposure to viral vaccinations prior to the initiation of the trial were utilized.  All steers 
were confirmed to be free from persistent infection (PI) with BVD and were confirmed 
seronegative to BVD and IBR prior to trial initiation.  Lack of PI was confirmed through 
evaluation of an ear notch sample by antigen capture ELISA at the Texas Veterinary Medical 
Diagnostic Laboratory (TVMDL, Amarillo, TX).  Blood serum samples were also tested at 
Texas Veterinary Medical Diagnostic Laboratory (TVMDL, Amarillo, TX) using serum 
neutralization tests to confirm sero-negativity to BVD and IBR.   
Treatments.  Animals were assigned to pens equipped with Calan® gated feed bunks (n 
= 4 per pen) based on animal height (to allow for optimum adjustment of the gates).  Pens were 
then stratified by average body weight and assigned to treatments.  Animals receiving different 
treatments were not commingled within pens to minimize potential artifact seroconversion due to 
contact among animals receiving different treatments.  
  Calves within a pen received one of three vaccination treatments:  Negative control 
(physiological saline), Arsenal 4.1®, Novartis Animal Health US, INC., Larchwood, IA, or 
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Vista™ 5 SQ, Intervet Inc., Millsboro, DE.  All treatments were applied at 2 ml subcutaneously 
in the neck, as per label directions. 
Intake.  Individual intake was measured with the use of the Calan gate system.  Prior to 
the start of the trial, animals were trained to eat out of the individual Calan gates.  Treatments 
were applied after training was complete.  Individual feed delivery was based on the prior day’s 
consumption and was recorded daily. Orts were recorded weekly (d 7, 14, 21, 28, 35, and 42). 
  Once the initial phase of the trial was completed, cattle were moved to a group feeding 
situation.  Steers were placed at random into two pens and fed ad libitum throughout the 
conclusion of the trial.  The diet fed throughout is presented in Table 10.   
  Sample collection.  Rectal temperature was measured via digital rectal thermometer on 
days 0, 1, 3, 7, 14 and 28 following treatment application.  Body weight was recorded at day -30, 
0, 14, 28, and 42 as part of the first phase of the trial.  During the second phase of the trial, steers 
were weighed every 28 days until they were harvested.   
  Blood samples were drawn via jugular venipuncture into evacuated tubes on days 0, 14, 
28 and 42 and sent to TVMDL for quantification of serum neutralizing antibody titers to BVD 
Type 1, BVD Type 2, and IBR.  On days 0 and 49, fat thickness over the 12th rib (fat thickness), 
longissimus dorsi face area (ribeye area, REA), and percentage intramuscular fat (IMF) were 
measured via ultrasonography with an Aloka 500V ultrasound unit fitted with a linear array 
probe by a certified technician.   
  Animals were fed to a common fat thickness endpoint based on visual estimation (10 
mm) and harvested in three groups.  All harvest groups had representatives from each treatment  
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Table 10.  Calculated composition (as fed) of basal diet fed to steers. 
Ingredient Percentagea
Basal diet composition
  Ground milo 20.00
  Ground corn 31.25
  Cottonseed meal 9.00
  Cottonseed hulls 25.00
  Molasses 10.00
  Premixb 3.00
  Ammonium chloride 0.25
  R-1500c 1.50
Dry Matter, % 88.9
Crude Protein, % 11.5
NEm (Mcal/kg) 1.60
NEg (Mcal/kg) 1.00
Crude Fiber, % 14.5
Calcium, % 0.85
Phosphorous, % 0.39
aAs-fed basis
bComposition of premix: ground limestone, 60%; trace mineralized salt, 16.7%
(NaCl, 98%; Zn, 0.35%; Mn, 0.28%; Fe, 0.175%, Cu, 0.035%, I, 0.007%, Co, 0.007%); 
mono-dicalcium phosphate, 13%; potassium chloride, 6.7%; Vitamin premix, 3.3%
(vitamin A, 2,200,000 IU/kg; vitamin D, 1,100,000 IU/kg, vitamin E, 2,200 IU/kg);
Zinc oxide, 0.33%.
cR-1500 contains 1.65 g monensin sodium (Rumensin™) per kg.
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group.  Group 1 was harvested at d 157, group 2 at d 192, and group 3 at d 283.  During the 
harvest process, hot carcass weight was secured and animal identity was transferred to its 
corresponding carcass.  Following a 48 h chill period, the carcasses were presented to USDA 
personnel for grading.  Trained personnel from Texas A&M University collected quality grade 
and yield grade data (USDA, 1996).  Ribeye area, kidney pelvic and heart fat, overall maturity, 
marbling, color, texture, firmness, heat ring, dark cutter, and hump scores measurements were 
collected according to the methods outlined by AMSA (1991).   
  Whole loin samples were secured following this chill period.  Samples were then 
transported to the Texas A&M University Meats Laboratory for further analysis.  Strip loins 
were fabricated into 2.54 cm steaks.  Steaks were vacuum packaged and stored at 2-4 °C in the 
dark until a 0, 14, or 21 day postmortem aging time was obtained.   
  Tenderness evaluation.  Steaks were thawed at 4 °C for 24 h and cooked to a medium 
degree of doneness (~70 °C).  Six 1.27 cm diameter round cores were removed parallel to the 
longitudinal orientation of the muscle fibers.  Cores were sheared perpendicular to the 
longitudinal orientation of the muscle fibers for the Warner Bratzler Shear (WBS) force 
determination. 
  Statistical analysis.  Mixed-model procedures of SAS (v. 9.1.3; SAS Institute, Cary, 
NC) were used for analyses.  Rectal temperature (°C) and dry matter intake (percentage of initial 
BW) were considered repeated measures of animals and pen nested within treatment was used as 
the random subject effect.  Due to the unequal spacing of time lags, a spatial power covariance 
structure was fit to the repeated measures model.   
  Serum-neutralizing antibody titer count data were transformed to log2 prior to analyses, 
and the results are expressed in this form (i.e., the values represent x in the form 2x; data were not 
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back-transformed for presentation). Average daily gain was computed as the average weight gain 
(lb) divided by time between weight collections (d) for specific time periods. Time periods used 
for ADG calculations were phase 1 (d 0 to 42), phase 2 (d 42 to harvest) and overall (d 0 to 
harvest). 
  Initial body weight (d -30) of the animals varied, while the dose of the vaccine treatment 
was constant, so that the potential for varying response to treatment as a function of BW at the 
time of treatment application existed. Therefore, for analyses of all response variables, a multi-
step covariance analysis process was performed to determine the influence of initial BW on 
responses as per Littell et al. (1996).  When initial weight interacted with treatments, estimates of 
treatment effects were established at the mean of the initial weight of the animals, one standard 
deviation above the mean and one standard deviation below the mean to define the nature of the 
interaction.   
  Carcass data were analyzed with harvest date as a random effect.  Day of aging was 
included as a main effect in the tenderness evaluation model.   
When analyses produced a significant F-test (P < .05), least squares means were 
separated through two-tailed t-tests (PDIFF option).  
Results and Discussion 
  Dry matter intake.  Dry matter intake was collected from days 0 to 42, and was 
evaluated as a proportion of body weight (PctDMI). Time, (P < 0.01) treatment, (P < 0.01) and 
their interaction (P < 0.01) influenced PctDMI in this experiment (Figure 29).  Intake sharply 
declined within the first six d of the trial, but recovered by the same magnitude over the  
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Figure 29.  Dry matter intake (% of initial body weight) for steers vaccinated with Arsenal 4.1, 
Vista SQ, or physiological saline (Control).a,b,c 
 
a: Time (day) effect, P < 0.01 
b: Treatment effect, P < 0.01 
c: Treatment X time effect, P < 0.01; steers treated with Arsenal 4.1 had lower intake than steers 
from other treatment groups from days 10 through 17. 
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subsequent 3 d.  Because all treatments exhibited a similar response over this time period, this 
variation in intake was likely due to handling and adaptation to measurement stress rather than to 
treatment effects.  However, from d 10 to 17 intake varied depending on treatment.  Cattle 
vaccinated with Vista™ 5 SQ had PctDMI intake similar to control cattle, but those vaccinated 
with Arsenal 4.1® had a second sharp decline in intake from d 9 to d 12, such that PctDMI in 
steers treated with Arsenal 4.1® was lower (P < 0.01) than PctDMI in Vista™ 5 SQ or Control 
treated steers, which did not differ (P = 0.42).  This was followed by an increase over the next 6 
days.  From d 18 to d 42, PctDMI did not differ among treatment groups.      
  Feed efficiency.  Feed efficiency was also evaluated for days 0 to 42, and was 
calculated as total ratio of total feed consumed to weight gain of each animal.  No treatment 
differences existed (P = 0.13) in phase one.  The initial weight of the animal was used as a 
covariate in the model (P = 0.06).  Least squares means for the feed to gain ratios were 8.52, 
9.17, and 11.29 for animals in the Arsenal 4.1®, Vista™ 5 SQ, and control treatment categories, 
respectively. 
  Rectal temperature.  Rectal temperature had a tendency (P = 0.08) to be affected by 
treatment and was significantly (P < 0.01) affected by day.   Rectal temperature had a tendency 
(P < 0.06) to be influenced by the interaction of treatment and day.  In this model, the covariate 
of initial body weight was significant (P < 0.01) and therefore included in final analysis.  For all 
days measured after initiation of the project, cattle in the control group had the numerically 
highest rectal temperatures followed by the cattle receiving the Vista™ 5 SQ vaccination and 
then by animals receiving the Arsenal 4.1® treatment.  However, the differences in temperatures 
did not become significantly different until days 14 and 28 (Figure 30).  On d 14 and 28, rectal 
temperature in cattle receiving Arsenal 4.1® was lower (P < 0.01) than cattle in the Control and 
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Figure 30.  Rectal temperatures over time of steers vaccinated with Arsenal 4.1, Vista SQ, or 
physiological saline (Control).a 
 
 
a: Treatment X time effect, P = 0.06 
b,c: Steers treated with Arsenal 4.1 had lower (P < 0.01) rectal temperature than those treated with 
Vista SQ or Control, which were similar (P > 0.5) 
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 Vista™ 5 SQ treatment groups.  Cattle receiving the Control and Vista™ 5 SQ treatments were 
similar (P > 0.21) for both d 14 and 28 rectal temperature. 
  Average daily gains.  Average daily gain was strongly influenced (P < 0.01) by the 
interaction between treatment and initial body weight in phase one (Figure 31).  This caused us 
to generate among treatment comparisons for ADG at the mean initial weight, one standard 
deviation below the mean initial weight, and one standard deviation above the mean initial 
weight.  From these estimates we were able to infer that cattle of different weight classes respond 
to the vaccinations differently.  When treatments were compared in the light weight category (-1 
SD) ADG was greatest in calves treated with saline (P < 0.01); those vaccinated with Vista™ 5 
SQ or Arsenal 4.1® treatments had statistically similar (P > 0.1) ADG. ADG was similar (P > 
0.5) among treatments when compared at mean initial BW. When compared within the heavy 
weight class (+1 SD) cattle that received Vista™ 5 SQ had greater ADG than those receiving 
saline injection (P < 0.01). Cattle receiving Arsenal 4.1® had ADG similar to those receiving 
Vista™ 5 SQ (P = 0.5); and tended (P = 0.11) to have ADG greater than those receiving saline.  
  In phase two, ADG was also strongly influenced (P < 0.01) by the interaction between 
treatment and initial body weight (Figure 32).  However, the direction of the interaction changed 
from that of phase one.  When treatments were compared in the light weight category   (-1 SD) 
ADG was different (P < 0.01).  ADG was greatest for cattle receiving Arsenal 4.1®, followed by 
those receiving Vista™ 5 SQ, and then by those in the control group.  At mean initial BW, 
animals receiving Arsenal 4.1® had greater (P < 0.05) ADG than those receiving the control 
treatment.  Vista™ 5 SQ was not significantly different than the other two treatments.  In the 
heavy weight class (+1 SD), no significant differences existed between the treatment groups.   
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Figure 31.  Initial period (d 0 to 42) average daily gain of steers vaccinated with Arsenal 4.1, 
Vista SQ, or physiological saline (Control) compared at initial body weights of -1 SD from mean 
initial BW, at the mean initial BW, or +1 SD from the mean initial BW. 
 
 
* Initial body weight X treatment interaction (P < 0.01). Treatment comparisons are depicted 
above, where within weight class, different superscripts differ (P < 0.05). 
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Figure 32.  Finishing period average daily gain of steers vaccinated with Arsenal 4.1, Vista SQ, 
or physiological saline (Control) compared at initial body weights of -1 SD from mean initial 
BW, at the mean initial BW, or +1 SD from the mean initial BW. 
 
* Initial body weight X treatment interaction (P < 0.01). Treatment comparisons are depicted 
above, where within weight class, different superscripts differ (P < 0.05). 
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Figure 33.  Overall average daily gain of steers vaccinated with Arsenal 4.1, Vista SQ, or 
physiological saline (Control) compared at initial body weights of -1 SD from mean initial BW, 
at the mean initial BW, or +1 SD from the mean initial BW. 
 
* No treatment differences were found (P = 0.20) and no treatment by weight interactions 
occurred (P = 0.48). 
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When overall ADG was evaluated, no treatment differences existed (P = 0.20) and no treatment 
by initial body weight interactions occurred (P = 0.48) (Figure 33). 
  Ultrasound measurements.  Animal body composition of phase one was measured 
through the use of ultrasonography.  Because animals were measured only at day 0 and day 49, a 
change in the measured values was calculated as the response variable.  For the change in ribeye 
area, no treatment differences were detected (Table 11).  Intramuscular fat deposition did not 
significantly differ due to treatment either (Table 12).  No treatment by initial weight interactions 
occurred for the change in rib-eye area or the intramuscular fat deposition. 
  We did find a difference (P < 0.01) in the change in fat thickness over the 12th rib due to 
treatment (Figure 34).  An interaction (P < 0.01) between initial weight and treatment also 
existed.  For lightweight cattle (-1 SD), administration of Vista™ 5 SQ resulted in a greater (P < 
0.01) increase in fat cover over the 12th rib than application of either Arsenal 4.1 or control 
treatments, which were similar (P = 0.76).  At mean initial BW, cattle receiving Vista™ 5 SQ 
had a greater (P < 0.01) fat thickness increase than the animals in the control group, while 
animals receiving Arsenal 4.1® had fat thickness change intermediate (P > 0.10) to the other 
treatment groups. When compared at heavy initial BW, cattle receiving Arsenal 4.1® and 
Vista™ 5 SQ had similar amounts of fat accretion (P = 0.56), while those receiving the control 
treatment tended to have a lesser amount (P = 0.09) of fat thickness change.  
  Titer response.  Both treatment (P < 0.01) and the treatment by day interaction (P < 
0.01) affected BVD Type 1 titer count (Figure 35).  Initial body weight was not a significant 
covariate with titer response for BVD Type 1, Type 2, or IBR (P = 0.83, 0.92, and 0.11 
respectively).  As animals were confirmed seronegative to BVD Type 1, BVD Type 2, and IBR 
prior to the initiation of the project, therefore on d 0, no treatment differences existed as were  
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Table 11.  Change in rib-eye area (cm2) over 42 d in steers vaccinated with Arsenal 4.1, Vista 
SQ, or physiological saline (Control). 
 
 
 
 
Treatment -1 Std SE Mean SE 1 Std SE
Arsenal 4.1 -0.009 0.09 -0.05 0.1 -0.1 0.15
Control 0.38 0.13 0.23 0.1 0.07 0.14
Vista SQ 0.51 0.1 0.50 0.1 0.48 0.09
Initial Weight
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Table 12.  Change in intramuscular fat deposition (%) over 42 d in steers vaccinated with 
Arsenal 4.1, Vista SQ, or physiological saline (Control). 
 
 
Treatment -1 Std SE Mean SE 1 Std SE
Arsenal 4.1 0.03 0.01 0.06 0.01 0.08 0.01
Control 0.03 0.01 0.05 0.01 0.08 0.01
Vista SQ 0.06 0.01 0.07 0.01 0.08 0.01
Initial Weight
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Figure 34.  Change in 12th rib fat thickness (cm) over 42 d in steers vaccinated with Arsenal 4.1, 
Vista SQ, or physiological saline (Control) when compared at initial body weights of -1 SD from 
mean initial BW, at the mean initial BW, or +1 SD from the mean initial BW. 
 
a: Vista SQ greater than Arsenal 4.1 or Control, P < 0.01; Arsenal 4.1 and Control similar (P = 
0.68).  
b: Vista SQ greater than Control, P < 0.01; Arsenal intermediate and not different from either 
Control or Vista (P > 0.2).  
c: Arsenal 4.1 and Vista SQ similar (P = .52) and greater than control (P < 0.01). 
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Figure 35.  Serum neutralizing antibody titer response (log2) to inoculation with BVD type 1 in 
steers vaccinated with Arsenal 4.1, Vista SQ, or physiological saline (Control) over 42 d. 
 
a: Treatment X day interaction, P < 0.01. All treatments differ, P < 0.01. 
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expected. No measurable increase in BVD Type 1 titer had occurred by d 14. By d 28 vaccinates 
had measurable antibodies to BVD Type 1.  On both d 28 and 42, Vista™ 5 SQ had the highest 
(P < 0.01) titer counts followed by Arsenal 4.1®., with control treated steers exhibiting no 
measurable titer to BVD Type 1. On both d 28 and 42, all treatment groups were significantly 
different (P < 0.01) from each other. 
  Treatment (P < 0.01) and the treatment by day interaction (P < 0.01) also affected BVD 
Type 2 titer count (Figure 36).  As with BVD Type 1, no animals had measurable antibody 
production to BVD Type 2 through d 14. By d 28, animals that had received a vaccine had 
measurable antibody production.  Animals that had received Vista™ 5 SQ had the greatest (P < 
0.01) increase in titer counts followed by the cattle that had received the Arsenal 4.1® vaccine.  
On d 42, animals in the Vista™ 5 SQ category had the greatest (P < 0.01) titer counts to BVD 
Type 2; the log2 titer for Arsenal 4.1® treated calves was approximately 40% of that for Vista™ 
5 SQ treated calves.  On d 28 and 42, all treatment groups were different (P < 0.01) from each 
other.  Treatment (P < 0.01) and the treatment by day interaction (P < 0.01) influenced 
production of antibody against IBR (Figure 37).  On d 0, no animals had measurable antibody 
against IBR.  At d 14, animals that had received Arsenal 4.1® had higher (P < 0.01) titer counts 
than those that had received Vista™ 5 SQ, which in turn had greater (P < 0.01) antibody 
production than animals receiving the control treatment.  These separations persisted at d 28 and 
d 42.   
  Carcass data.  Hot carcass weight was influenced (P < 0.01) by treatment.  Animals 
receiving Vista™ 5 SQ had heavier (P < 0.01) hot carcass weights than those receiving either 
Arsenal 4.1® or control treatments.  Hot carcass weights for animals receiving either Arsenal 
4.1® or control treatments were not significantly different (P = 0.27).  Rib-eye area was not
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 Figure 36.  Serum neutralizing antibody titer response (log2) to inoculation with BVD type 2 in 
steers vaccinated with Arsenal 4.1, Vista SQ, or physiological saline (Control) over 42 d. 
 
a: Treatment X day interaction, P < 0.01. All treatments differ, P < 0.01. 
 
 
 
 
99
 
IBR
0.0000
0.5000
1.0000
1.5000
2.0000
2.5000
3.0000
Day 0 Day 14 Day 28 Day 42
Ti
te
r (
lo
g 
ba
se
 2
)
Arsenal 4.1
Control
Vista SQ
 
a a a 
Figure 37.  Serum neutralizing antibody titer response (log2) to inoculation with IBR in steers 
vaccinated with Arsenal 4.1, Vista SQ, or physiological saline (Control) over 42 d. 
 
 
a: Treatment X day interaction, P < 0.01. All treatments differ, P < 0.01. 
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affected by treatment, day, or the treatment by day interaction (P > 0.40).  The kidney, pelvic, 
and heart fat measurement was also not affected by treatment, kill day, or the treatment by kill 
day interaction (P > 0.18).  Furthermore, YG was not affected by treatment, kill day, or the 
treatment by kill day interaction (P > 0.17).  Marbling score was affected by treatment (P < 
0.01).  Kill day and treatment by kill day was not significant (P = 1.00).  Animals in the Arsenal 
4.1® treatment group had lower (P < 0.01) marbling scores than those in the control or Vista™ 5 
SQ treatment groups.  Marbling scores for animals in the control and Vista™ 5 SQ treatment 
groups were similar (P = 0.11).  No treatment, kill day, or treatment by kill day effects were 
found (P > 0.20). 
  Shear data.  No treatment (P = 0.15) nor treatment by day of aging interaction (P = 
0.92) differences occurred for the tenderness data (Table 13).  Day of aging had a large (P < 
0.01) impact on tenderness.  Steaks aged for either 14 or 21 d had lower (P < 0.01) tenderness 
scores than those aged for 0 d.  No differences (P = 0.33) were seen between the 14 and 21 d 
aging period.    
  Underlying morbidity (which we were not able to measure) may have affected the 
performance and efficiency of steers in this trial.  However, any effects on ADG that may have 
been seen during the early portions of the study were not seen when the trial was taken to 
completion.  As most research from confined feeding experiments have indicated, a weight loss 
associated with early morbidity is usually compensated within a short period (Gaylean et al., 
1999; Pinchak et al., 2004).  The lighter animals who had been vaccinated had reduced gains 
below that of those who had not received a vaccination, possibly due to underlying morbidity 
issues.  Those lightweight animals then compensated throughout the feeding period, so that no 
differences in ADG could be seen when the entire feeding period was evaluated. 
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Table 13.  Warner-Bratzler shear force values in steers vaccinated with Arsenal 4.1, Vista SQ, or 
physiological saline (Control) and whose subsequent steaks were aged for 0, 14, or 21 d. 
 
 
 
Variable Arsenal 4.1 Control Vista SQ SE 0 14 21 SE
WBSF, kg 3.08 2.77 2.97 0.1 3.41 2.79 2.63 0.1
Vaccine Treatment Day of Aging
 
 
a : Treatment effect, P = 0.15 
b : Day of aging effect, P < 0.01 
c : Treatment x Day of Aging effect, P = 0.92 
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  Findings of the ultrasonography measurements are consistent with intake and gain data.  
The lack of change in rib-eye area based on treatment differences suggests that the treatments did 
not alter lean tissue deposition.  In this experiment, differences in ADG among treatments by 
initial weight class were reflected in differences among change in subcutaneous fat thickness. 
This may suggest alterations in nutrient partitioning or efficiency of energy retention during the 
early stages of the feeding period. 
  In this study, both vaccines significantly increased titers for BVDV Type 1 and Type 2.  
No significant differences could be seen between vaccines for BVDV Type 1.  However, 
treatment differences did exist for BVDV Type 2 (P < 0.05).  These results are consistent with 
expectations, as Vista™ 5 SQ vaccine has BVD Type 2 antigen while Arsenal 4.1® does not, 
relying instead upon cross-reacting antibodies generated in response to the BVD Type 1 antigen.   
  While overall average daily gains were not different, setbacks in weight increases early 
on, led to treatment differences in hot carcass weights.  Lower marbling scores for the Arsenal 
4.1® treated animals cannot be explained.  More research is needed, to help understand if this is 
due to the vaccine, or just an artifact of this data set. 
Conclusions 
  Different vaccines may have different economic consequences depending upon the 
sector of the beef industry in which they are used.  Across the entire trial, the vaccines performed 
equally.  While in the early periods, performance differences existed, the differences disappeared 
by the end of the trial.  As both vaccines stimulated adequate antibody production, differences in 
early weight gains and the length of time and/or phase of ownership may be a driver in the 
decision as to which vaccine should be used.  As no clear differences in tenderness values of 
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carcass characteristics were found, it is our belief that both vaccines adequately stimulated the 
immune system without causing decreases in the profitability of the animal.  
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CHAPTER V 
EFFECTS OF SUPPLEMENTAL COPPER AND SELENIUM ON PERFORMANCE OF 
CALVES ENTERING THE TEXAS A&M UNIVERSITY RANCH TO RAIL PROGRAM 
 
Introduction 
A calf encounters significant stressors during the weaning, shipping, and commingling 
stages of his life.  Upon entry into a feedyard, the animal’s immune system is challenged with a 
variety of pathogens which serve to threaten if not weaken the animal.   Often, the physical and 
pathological stressors seen at this time suppress the immune function of the calf resulting in 
economic losses associated with production losses. 
 While the actual mineral requirements of stressed calves do not seem to be greater than 
those of unstressed calves (Cole, 1993), pre-weaning nutritional deficiencies may interact with 
the pathological stressors to further hinder the immune function of the animal.  In an effort to 
mitigate these deficiencies, receiving diets are often fortified with minerals.  Gaylean and 
Hubbert (1995) reported that feed intake by lightweight stressed calves is low shortly after 
entering the feedyard.  Low feed intake results in lowered nutrient intake, thereby, making 
correction of nutritional deficiencies difficult (Gaylean et al., 1999).   
The trace minerals selenium and copper have been associated with impaired performance of 
cattle entering feedlots (Xin et al., 1991; Reffet et al., 1988).  Copper deficiency has been shown 
to reduce growth rate (Gengelbach et al., 1994; Kegley and Spears, 1994) and immune function 
of calves (Gengelbach et al., 1997).  Whereas selenium supplementation has been associated 
with increased serum antibody titers (IgG) in growing beef cattle, thus enhancing immune 
response to illness (Droke and Loerch, 1989; Nicholson et al., 1991 Swecker et al., 1989, 2008).   
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The objectives of the present study were to determine: 1) the effects of mineral supplements 
on incidence of bovine respiratory disease, 2) the response of animals supplemented with a 
mineral to treatment against the disease, and 3) if treatment with a mineral supplement affected 
feedlot performance in steers enrolled in the Texas Ranch to Rail program.    
Materials and Methods 
    Animals.  Three hundred and fifty-two animals representing 88 ranches were used for 
this experiment.  The calves were part of one year of the Texas A&M University ranch to rail 
program and entered the King Ranch Feedyard, Kingsville, Texas, during the third week of 
October, 1994.  Cattle used for this trial originated from Texas.  Prior to feedyard arrival, 
producers completed questionnaires as to the cattle background management.  Upon arrival, 
cattle were assigned a Texas A&M University ear tag, implanted, weighed, given an anthelminic, 
bled, vaccinated both with a respiratory  and a clostridial vaccine, and treated with the 
appropriate mineral treatment.   Cattle were fed to a common fat thickness endpoint utilizing a 
diet common to the commercial feedlot.  Carcass data including hot carcass weights, KPH fat 
thickness, marbling scores, and USDA yield grade (calculated) were collected by trained Texas 
A&M University personnel 48 h post slaughter at a commercial abbatoir (Sam Kane Beef 
Packing, Corpus Christi, TX).   
 Experimental treatments.  Four animals from each ranch were randomly assigned to 
this project and randomly assigned to one of 4 treatments: control, copper, selenium, and 
copper/selenium mixture.  Animals in the control group (CON) received no treatment.  Those in 
the copper treatment (CU) were orally administered a Copasure bolus (Schering-Plough Animal 
Health, Kenilworth, NJ) containing 25 mg of copper oxide needles.  Calves in the selenium 
treatment (SE) group received a subcutaneous injection of 3 ml of MU-SE (Schering-Plough 
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Animal Health, Kenilworth, NJ) containing 10.95 mg sodium selenite and 50 mg Vitamin E.  
The animals in mixture (MIX) treatment group received both an oral administration of a 
Copasure bolus as well as a subcutaneous injection of MU-SE. 
 Initial blood samples were drawn into evacuated blood tubes prior to administration of 
the treatments to determine initial mineral status.  Samples were sent to the Texas A&M 
University Veterinary Medical Diagnostic Laboratory for analysis of copper, selenium, and zinc 
levels.  Initial mineral status was assigned to a 4-point scale as deficient, borderline, adequate or 
high as described in Mineral Levels in Animal Health, 1994 (Pulls, 1994).   
Interactions with pre-feedlot practices.  Ranches consigning cattle to the program were 
asked to fill out questionnaires asking about vaccination practices, weaning periods, 
backgrounding periods, and nutrition of calves prior to entry into the Ranch to Rail Program.  
Vaccination practices were grouped based on type of vaccine given: clostridials, bovine 
respiratory disease, or other.  Bovine respiratory disease was further broken into the categories of 
modified-live virus vaccine, killed vaccine, or altered vaccine.  Vaccinations were also grouped 
as pre-weaning and post-weaning prior to entry into the feedlot.  Period from weaning to entry 
into the feedlot was also categorized in this data set.  Categories were Bac14 (< 21 d prior to 
feedlot entry), Bac 21 (< 45 d but > 21 d) and Bac 45 (> 45 d).  All animals in this study received 
at least one vaccination prior to entry into the feedlot.  Nutrition practices were grouped into one 
of six categories: None (Nothing given); Past + Supp (Pasture plus a supplement); Dry + Hay 
(Drylot plus hay); Dry + Hay + Supp (Drylot plus Hay plus a supplement); Drylot + TMR 
(Drylot plus total mixed ration). 
Statistical analysis.  Data were analyzed using the MIXED procedures of SAS (Release 
8.1, SAS Inst. Inc., Cary, NC).  The model included the fixed effects of treatment, mineral status, 
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and treatment x mineral status, with Ranch included as a random effect.  Treatment means were 
computed with the LSMEANS option.  When an F-test was significant (P < 0.05), individual 
treatment means were separated with pairwise t-tests among all means.  
Results and Discussion 
Mineral status of calves.  Results for incoming mineral status of the calves at feedyard 
arrival are shown in Table 14.  In regard to serum copper levels, only 3 calves were classified as 
deficient, 304 were determined to be marginal, and 43 were classified as adequate.  No calves 
were found to have high levels of circulating copper.  In regard to selenium status classification, 
8 were deficient, 171 were marginal, and 171 were adequate.  The numbers of animals 
determined to be deficient, marginal, adequate, or high for circulating zinc levels were 6, 18, 
314, and 12, respectively. 
Production responses.  No significant interactions were found between treatment and 
initial mineral status.  Therefore, only main effects of the treatments are discussed for production 
responses (summarized in Table 15).  Final body weight was not significantly altered by 
supplementation with either copper, selenium, or a combination of copper and selenium.  Least 
squares means of final body weights were 539.46, 529.83, 543.91, 536.52 kg for the Con, Cu, 
Mix, and Se treatment categories, respectively.  Average daily gains were not affected by 
treatment.  Average daily gains ranged from 1.35 kg/day for the CU group to 1.42 kg/day for the  
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Table 14.  Mineral status percentages of incoming ranch to rail calves. 
 
 Mineral (%) 
 Cu Se Zn 
Deficient 0.86 2.28 1.72
Marginal 86.86 48.86 5.14
Adequate 12.28 48.86 89.71
High 0 0 3.43
Total       100       100        100 
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Table 15.  Effects of supplemental copper and selenium on feedlot performance of growing beef animals. 
 
             
     Treatment 1
Initial Mineral Status 
Interaction (P‐value) 3
Item  Con  Cu Mix Sel P‐value SE2 1 2 3
Initial BW, kg  264.25  259.85 270.39 259.27 0.82 11.23 0.47 0.23 0.34
Final BW, kg  539.46  529.83 543.91 536.52 0.97 12.40 0.13 0.48 0.72
ADG, kg  1.39  1.35 1.42 1.39 0.95 0.06 0.81 0.55 0.41
Total COG ($ / lb) 4 0.52  0.54 0.52 0.52 0.88 0.02 0.74 0.58 0.51
Medicine Cost ($) 4 23.52  22.51 21.00 20.72 0.43 6.75 0.09 0.42 0.73
Gross Return ($) 4 467.45  452.51 480.40 460.00 0.84 29.00 0.55 0.78 0.57
Net Return ($) 4,5 74.29  63.06 77.74 72.40 0.82 23.60 0.23 0.88 0.60
1 Con = control (no mineral supplementation); Cu = copper; Mix = copper and selenium; and Sel = selenium 
2 Pooled SE of treatment means                 
         
           
       
3 Interactions: 1) Treatment x Initial copper status;  2)  
   
 
4 US Dollars   
5 Gross Return minus initial value of animal as determined by trained personnel 
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Mix group.  Total cost of gain and medicine costs were not significantly different among 
treatments.  Costs of gain were $0.52 USD for the Con, Mix, and Sel treatment groups.  Cost of 
gain increased to $0.54 USD for the Cu group.  Average medicine cost ranged from $20.72 to 
$23.53 USD for the treatment groups.  Neither gross nor net returns were affected by treatment 
(P > 0.05). 
Carcass results.  Carcass traits were measured when animals were harvested at the 
completion of the feeding period.  Several treatment by initial mineral status interactions (P < 
0.05) occurred.  Treatment by initial copper interaction was observed for dressing percentage 
(Figures 38).  A treatment by initial selenium interaction occurred for percentage of kidney, 
pelvic, and heart fat (Figure 39).  As we were not able to find similar interactions within the 
literature, we cannot determine whether these can be replicated or are just an artifact of this 
particular data set. 
Interestingly we found that a treatment by initial zinc interaction occurred for hot carcass 
weight, dressing percentage, and rib-eye area (REA)(Figures 40,41,42).  In all three instances, 
animals in the Mix group had lower levels when serum zinc was high at initial feedlot entry.  
Pulls, 1994, reported that high levels of zinc may cause calves to be more susceptible to 
pneumonia.  While we did not see an increase in morbidity in these cattle, we suspect that 
animals in the Mix group could have had pneumonia but showed no outward clinical signs. 
No differences in the initial mineral status or the mineral treatment main effects were seen 
for any of the carcass traits (Table 16).  USDA yield grade had a tendency for differences among 
treatments.  Animals in the CON group had the highest yield grades at 2.25 followed by MIX, 
SE, and CU respectively.  Least squares means for hot carcass weights were 337.3, 325.46, 
339.44, and 336.76 kg for the CON, CU, MIX, and SE treatment groups.  Mean dressing  
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Table 16.  Effects of supplemental copper and selenium on carcass characteristics of finishing 
beef animals. 
 
             
  Treatment     
Initial Mineral Status 
Interaction (P‐value) 3
Item  Con  Cu  Mix  Sel 
P‐
value  SE2 1  2 3
HCW, kg  337.3  325.46 339.44 336.76 0.27 13.06 0.91  0.99 0.04
Dressing 
percent  62.73  61.52 62.51 61.98 0.21 2.20 0.01  0.98 0.01
LM area, cm2 86.75  87.32 91.34 88.05 0.21 5.18 0.51  0.29 0.04
KPH, %  2.2  2.15 2.28 2.16 0.73 0.18 0.23  0.04 0.84
USDA yield 
grade  2.25  1.97 2.09 2 0.1 0.20 0.28  0.61 0.40
     1 Con = control (no mineral supplementation); Cu = copper; Mix = copper;  
selenium; and Sel = selenium               
     2 Pooled SE of treatment means               
     3 Interactions: 1) Treatment x Initial copper status;  2) Treatment x 
initial selenium status;  3) Treatment x initial zinc status         
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Figure 38.  Dressing percentage for incoming beef calves to the ranch to rail program at varying 
initial serum copper levels. 
* Treatments include: Con (Controls – no supplementation); Cu (Copper – animals 
supplemented with Copasure bolus, Schering-Plough Animal Health, Kenilworth, NJ); Se 
(animals injected with MU-SE, Schering-Plough Animal Health, Kenilworth, NJ); and Mix 
(animals treated with both the Cu and Se treatments). 
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Figure 39.   Kidney, pelvic, and heart fat percentage of beef calves in the ranch to rail program 
at varying initial serum selenium levels. 
 
* Treatments include: Con (Controls – no supplementation); Cu (Copper – animals 
supplemented with Copasure bolus, Schering-Plough Animal Health, Kenilworth, NJ); Sel 
(animals injected with MU-SE, Schering-Plough Animal Health, Kenilworth, NJ); and Mix 
(animals treated with both the Cu and Sel treatments). 
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Figure 40.  Hot carcass weights of beef calves in the ranch to rail program at varying initial zinc 
serum levels. 
 
* Treatments include: Con (Controls – no supplementation); Cu (Copper – animals 
supplemented with Copasure bolus, Schering-Plough Animal Health, Kenilworth, NJ); Sel 
(animals injected with MU-SE, Schering-Plough Animal Health, Kenilworth, NJ); and Mix 
(animals treated with both the Cu and Sel treatments). 
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Figure 41.  Dressing percentages of beef calves in the ranch to rail program at varying initial 
zinc serum levels. 
 
* Treatments include: Con (Controls – no supplementation); Cu (Copper – animals 
supplemented with Copasure bolus, Schering-Plough Animal Health, Kenilworth, NJ); Sel 
(animals injected with MU-SE, Schering-Plough Animal Health, Kenilworth, NJ); and Mix 
(animals treated with both the Cu and Sel treatments). 
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Figure 42.  Longissimus dorsi area (cm2) of beef calves in the ranch to rail program at varying 
initial zinc serum levels. 
 
* Treatments include: Con (Controls – no supplementation); Cu (Copper – animals 
supplemented with Copasure bolus, Schering-Plough Animal Health, Kenilworth, NJ); Sel 
(animals injected with MU-SE, Schering-Plough Animal Health, Kenilworth, NJ); and Mix 
(animals treated with both the Cu and Sel treatments). 
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percentages ranged from 61.5% to 62.7%.  REA of the groups had means from 86.75 to 91.3 
cm2. 
Interactions with pre-feedlot practices.  Ranches consigning cattle to the program were 
asked to fill out questionnaires asking about vaccination practices, weaning periods, 
backgrounding periods, and nutrition of calves prior to entry into the Ranch to Rail Program.  
Vaccination practices were grouped based on type of vaccine given: clostridials, bovine 
respiratory disease, or other.  Bovine respiratory disease was further broken into the categories of 
modified-live virus vaccine, killed vaccine, or altered vaccine.  Vaccinations were also grouped 
as pre-weaning and post-weaning prior to entry into the feedlot.  Period from weaning to entry 
into the feedlot was also categorized in this data set.  Categories were Bac14 (< 21 d prior to 
feedlot entry), Bac 21 (< 45 d but > 21 d) and Bac 45 (> 45 d).  All animals in this study received 
at least one vaccination prior to entry into the feedlot.  Nutrition practices were grouped into one 
of six categories: None (Nothing given); Past + Supp (Pasture plus a supplement); Dry + Hay 
(Drylot plus hay); Dry + Hay + Supp (Drylot plus Hay plus a supplement);  Drylot + TMR 
(Drylot plus total mixed ration). 
 No mineral treatment by vaccination practice interactions were seen in this data set.  In 
addition, no mineral treatment by backgrounding period or mineral treatment by nutrition 
interactions were observed.  The main effects of the practices associated with the questionnaires 
are discussed in the companion paper to this.  Therefore, we will not discuss the main effects 
here. 
Results of the initial selenium levels are fairly consistent with findings of Dargatz and Ross 
(1996) who reported that in the Southeast 29% of cattle not supplemented with a trace mineral 
supplement were severely deficient in selenium; 32% were marginally deficient, 31% were 
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adequate, and 8% had highly adequate levels.  Our results tended to have more animals clustered 
in the marginally deficient or adequate ranges than they found.   
It could be said that it is disappointing that we found no performance differences among 
mineral treatments.  However, the lack of differences is consistent with findings of other 
researchers.  Wright et al. (2000) found no production differences when they supplemented 0.3 
mg  Se/kg DM, and their average daily gains (ADG) for the supplemented cattle (0.98 kg/d) were 
slightly less from the gain we observed.  Ward et al. (1997) reported that supplementation with 5 
mg Cu had no effect on ADG in steers fed corn-silage based diets regardless of Mo or S addition.  
Gaylean et al. (1995) also did not show differences between ADG of steers fed receiving diets 
supplemented with Cu lysine or CuO.  Nicholson et al. (1991) concluded that no differences 
were found in pattern of weight gains of calves fed low selenium or selenium supplemented diets 
regardless of initial selenium status of the calves.   
For immune functions based on supplementation, Wright et al. (2000) found no differences 
in antibody titers to Bovine herpes virus-1 and Bovine viral diarrhea based on mineral treatment.  
Furthermore, Reffett et al. (1986) reported that in stressed calves, selenium injection had no 
effect on antibody titers to infectious bovine rhinotracheitis virus or parainfluenza type-3 viruses.  
Dill et al. (1990) reported that humoral immune response did not increase with 3.25 mL of 
injectable ZnO suspension, Cu (2 mL of Moly-Cu), or Se (1 mL of Mu-Se / 90.8 kg BW) + Cu in 
steers fed diets deficient in these minerals.  While we did not measure antibody titers, our lack of 
differences in medicine costs and gains likely indicate, as they found, that immune performance 
was probably not altered by treatment.  Our results agree with the results of Beck et al. (2001) 
and Stanton et al. (2001) who reported that trace mineral supplementation treatment had no 
influence on morbidity or mortality rates.   
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The interesting thing that we did find in this study is that steers entering the feedlot with 
high levels of circulating zinc had decreased carcass weights, dressing percentages, and rib-eye 
areas when supplemented with both copper and selenium.  While it can only be hypothesized that 
the high levels of zinc caused animals to be susceptible to pneumonia, we cannot understand how 
supplementing copper and selenium added to this effect.  At this time, we do not understand why 
this interaction occurred.  More research needs to be done in this area to understand the inter-
relationship between high levels of zinc and supplementation with both selenium and zinc or if 
these results can be repeated. 
Conclusions 
Selenium and copper supplementation did not enhance ADG or carcass characteristics by 
correcting a possible deficient state in trace mineral levels.  No differences in morbidity or 
mortality were observed based on the treatments given in this study.  These results are in 
agreement with supplementation of these micronutrients to animals with adequate status is not 
likely physiologically beneficial to the animal or economically beneficial to the producer. 
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 CHAPTER VI 
EVALUATION OF MANAGEMENT PRACTICES AT THE COW/CALF LEVEL ON 
FEEDLOT PERFORMANCE AND CARCASS TRAITS: RESULTS OF THE TEXAS A&M 
RANCH TO RAIL PROGRAM 
 
 
Introduction 
Marketing practices in the US beef cattle industry can result in varying periods of stress, 
nutritional deficiencies, and exposure to infectious agents when calves are commingled from 
various sources, transported to distant sites, and changes in diet, feed intake, or both are abrupt 
(Step et al., 2008).  These periods of stress result in increased morbidity and mortality which 
result in substantial losses for the US beef feeding industry.   
Morbidity and mortality in feedlots are highly attributable to the bovine respiratory disease 
complex (BRD).  Duff and Galyean (2007) reported that limited data and practical experiences 
have provided evidence that the effects of BRD on beef cattle morbidity and mortality can be 
decreased through pretransport preventative health programs commonly referred to as 
preconditioning, which may include vaccination for various infectious agents, anthelmintic 
treatments, exposure to feed bunks and troughs, and delayed shipment for 3 to 6 wk after 
weaning.  In general, preconditioning programs ensure that animals have been weaned for a 
certain amount of time (usually 30 to 45 d), vaccinated (clostridial and viral vaccines), treated 
with an anthelmintic, castrated, dehorned, and accustomed to feed bunks and water troughs. 
Preconditioning programs are designed to prepare a weaned calf for the “stresses” that may 
occur when it (1) is commingled with cattle from other sources and unknown health status; (2) is 
placed in an environment that maximizes exposure to infectious pathogens; (3) has a 
compromised immune system and cannot adequately protect itself against pathogens; (4) is 
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placed in environmental conditions that contribute to stress (temperature changes, dust, 
transportation, crowding, new feed and water delivery methods etc.)(Step et al., 2008).  
However, much debate occurs because of limited data, as to the feedlot performance of calves 
that have experienced different preconditioning programs.  To provide meaningful data to this 
issue Texas Ranch to Rail data were evaluated with objectives to: (1) determine which kinds of 
preconditioning practices were being used; (2) answer if specific ranch-level regimens could 
result in performance differences for cattle in the feeding phase; (3) determine if management 
decisions at the cow/calf level can influence carcass characteristics after the feeding period.     
Materials and Methods 
Cattle (n = 12,063) were entered in the Texas A&M University Ranch to Rail Program from 
1995 to 2001.  Due to incomplete data, we were only able to use 7,614 animals sent from 247 
ranches during the years of 1996 to 2000 (2,193 were not included due to missing background 
sheets; 2,045 were not included because of missing carcass data; 211 were not included because 
missing both background and carcass information).  The number of steers per ranch ranged from 
1 to 132.  Steers included a variety of genetic types typical in the southwestern United States.  
Weight of steers entering the feedlot ranged from 149 to 481 kg, with the vast majority falling 
between 191 and 362 kg.   
Producers were allowed to send their cattle to a feedyard in the panhandle of Texas (north) or 
to a south Texas feedyard (south).  Cattle sent north, were fed at Swisher County Cattle Feeders, 
Tulia, Texas.  Cattle sent south were fed at either Hondo Creek Cattle Co. in Edroy, Texas or at 
the King Ranch Feedyard, Kingsville, Texas.  Producers were asked to fill out background 
information and include it with the cattle at time of receiving.  Background surveys asked for: 
name of ranch, location of ranch, date of calf birth, date of weaning, any internal parasite control 
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given, any external parasite given, any implant given, any vaccine administered, and what 
nutritional program was used.  Survey data were entered into an excel spreadsheet as 
standardized value based on responses to survey.  For example, when asked what pre-weaning 
shot was given a producer may respond with a particular brand name or give a generic term such 
as a clostridial.  When a particular brand was referenced, a drop down list in excel linked the 
answer to a series of pre-determined generic values.  Generic values consisted of things such as: 
clostridial, viral, modified-live, killed, altered, etc.     
Cattle were received at the feedlot on a single day in mid-November each year.  Cattle were 
managed according to standard procedures in place at the respective feedlot; however, 
management practices were not identical across years or feedlots.  Cattle were diagnosed as 
morbid based on subjective visual appraisal by the feedlot staff.  Upon arrival, all steers 
individually weighed, identified, administered a growth-promoting implant, and given 
preventative pharmaceuticals based on the judgment of feedlot management.  Calves were 
assigned an initial market value by a trained USDA feeder calf grader upon entry into the 
feedyard based on weight, frame and muscle score, and current medical conditions.  These 
values were used in calculations for net returns.  Steers were processed for secondary application 
of implants in January or February each year.  
Individual intake was not evaluated as animals were fed as groups; however, intake was 
calculated as total pounds fed per day divided by total of animals within each pen.  Cattle were 
harvested at a commercial facility within a 200 mile radius of the feedyard.  Hot carcass weight 
(HCW) was collected at slaughter and longissimus muscle area, fat thickness, kidney, pelvic and 
heart fat (KPH), calculated yield grade, and USDA marbling score and quality grade were 
evaluated by independent data collection services following chilling.   
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Statistical analysis.  Separate analyses were conducted to evaluate different treatment 
classifications on the feedlot and carcass traits.  Treatment classifications included (1) morbidity, 
(2) backgrounding period, (3) nutritional strategy, (4) clostridial versus viral vaccine, (5) type of 
viral vaccine given, and (6) other types of vaccines given.  For all dependent variable analyses, 
the Mixed procedure of SAS (SAS Inst. Inc., Cary, NC) was utilized with ranch nested within 
year as a random term.  Individual steer was considered the experimental unit for all analyses. 
To study impacts of morbidity, steers were categorized as either healthy (receiving no 
treatment) or sick (receiving at least one medical treatment).  The effect of morbidity on ADG, 
days on feed, HCW, fat thickness, longissimus muscle area, calculated yield grade, total 
medicine cost, gross income, and net return was evaluated.  The FREQ procedure of SAS (SAS 
Inst. Inc., Cary, NC) was used to determine number of animals per treatment group.  A Chi-
square test was utilized to evaluate the categorical distribution of USDA quality grade. 
In evaluation of backgrounding effects, steers were grouped according to the amount of time 
from weaning to shipping to the feedyard.  Treatment groups included: none (animals were 
weaned the day of shipping); 1-14 (animals were weaned for no more than 14 days prior to 
shipping); 15-21 (animals were weaned for no less than 14 d and no more than 21 d prior to 
shipping); and 22-45 (weaning to shipping time was greater than 21d and less than 45).  Analysis 
was conducted as noted for the morbidity analysis.  This analysis included backgrounding 
period, morbidity (yes/no) and the backgrounding by morbidity interaction as fixed effects.   
For the nutritional strategy evaluation, calves were grouped depending upon the type of 
nutritional strategy that was provided on the incoming information sheet.  Nutritional strategies 
included: pasture only (pasture); pasture plus a supplement (Past + Supp); drylot plus hay (Dry 
+ Hay); drylot plus hay plus a supplement (Dry + Hay + Supp); drylot plus total mixed ration 
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(Drylot + TMR); and background feeding information not available (Not Reported).  
Nutritional strategy and morbidity were included in the model as fixed effects. 
For the clostridial versus viral vaccination strategies calves were grouped as whether or not 
they had a clostridial vaccination and whether or not they had a viral vaccination prior to entry 
into the feedlot.  All vaccines were characterized based on the Compendium of Veterinary 
Products (Bayer Animal Health, 2006).  Clostridial (yes/no), viral (yes/no), and the clostridial by 
viral interaction were included in the model as fixed effects.  There was a lack of balance across 
vaccination classifications as 5,338 steers were reported as having both vaccines, and only 180 
steers were reported as not receiving either.  Due to the fact that so many had received both 
vaccinations, we cannot fairly compare the main effects.  Therefore, the interaction of the two 
effects received the main focus.  
Of steers receiving a viral vaccine, the vaccine was characterized as either killed vaccine 
(Kill), modified-live virus vaccine (MLV), altered vaccine (Alt), or the combination of any two.  
No animals received a combination of shots that resulted in the combination of a Kill and an Alt.  
The statistical analysis was performed in the same manner as the morbidity analysis.  However, 
type of vaccine, morbidity (yes/no), and type of vaccine by morbidity interaction were included 
as fixed effects in the model. 
Another analysis was performed using other vaccines as the treatment categories.  
Treatments included: lepto-spirosis (lepto), haemophilus somnus (somnus) and lepto-spirosis 
plus haemophilis somnus (lepto + somnus).  Animals receiving these vaccines also had been 
vaccinated with some type of clostridial vaccine.  The fixed effects of other vaccine treatment, 
morbidity (yes/no) and the interaction were included in the model. 
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Simple linear correlations were calculated through PROC CORR of SAS (SAS Inst. Inc., 
Cary, NC) among response variables.   
Results and Discussion 
Morbidity.  During the feeding period, 18% (1,399) of the 7,614 steers showed signs of 
morbidity.  This percentage falls within published reports of morbidity rates (Waggoner et al., 
2007).  Our data set did not allow us to determine how many times each calf was pulled and 
treated for morbidity.  When morbidity was analyzed as a treatment variable, significant 
differences were found for many traits.  Final body weights were significantly affected by 
morbidity and were 8 kg lighter for calves that had been treated for an illness at least once during 
the feeding period.  Days on feed was also significantly increased by morbidity, and calves that 
were morbid averaged 6 days longer in the feeding period.  Average daily gains tended (P = 0.8) 
to be affected by morbidity.  Calves that were morbid gained .4 kg/d less than calves that did not 
get sick.  Hot carcass weights, dressing percentages, KPH, and yield grades were significantly 
different for healthy and treated steers.  A strong tendency (P = 0.02) occurred for difference in 
fat thickness.  Sick calves had significantly lower hot carcass weights, dressing percentages, and 
yield grades than healthy animals.  Differences (P < 0.01) existed for all of the financial 
measurements that were analyzed.  Medicine costs averaged $25.60 per animal that was treated 
due to illness, and healthy animals returned an additional $58.81 in gross returns over sick 
calves.   
Morbidity had a tendency (P = .10) to have an effect on quality grade; 42% of the healthy 
animals had choice carcasses while only 31% of the sick animals graded choice.  If the animal 
was treated at least once, there was a 44.61% chance that its carcass would not grade choice.  
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However, it the animal remained healthy throughout the feeding period, the probability of it not 
grading choice decreased to 32.61%. 
In a similar Ranch to Rail program, 22% of steers received medical treatment for morbidity 
(Waggoner et al., 2007).  Our 18% morbidity rate is less than their number and less than the 
23.9% rate reported by USDA-APHIS (2001).  However, it is higher than 8% rate reported by 
Edwards (1996) for Midwestern feedlots from 1979 to 1994.  We believe that our lower 
morbidity results could be due in part to ranch management and producer education.  We expect 
that producers enrolling in this program tended to be more progressive in their management and 
therefore the resulting calves may have less morbidity when reaching the feedlot, and the Ranch 
to Rail Program has had a producer education component.   
Our results are consistent with several studies, who reported reduced ADG in steers receiving 
medical treatment during the feeding period (Van Donkersgoed et al., 1993; McNeil et al., 1996; 
Wittum et al., 1996; Gardner et al., 1999; Waggoner et al., 2007).  Waggoner et al. (2007) 
hypothesized that lower ADG among the clinically ill cattle likely resulted from alterations in 
nutrient portioning and suppressed intake.  As we did not measure individual intake in this study, 
we can only speculate that this may have occurred for the cattle in this program as well.   
Hot carcass weight, fat thickness, and calculated yield grade were different for healthy and 
treated steers.  These results are consistent with findings of Gardner et al. (1999) who reported 
greater fat thickness and yield grades for steers that were not treated for respiratory disease.  
However, these finding disagree with the findings of Waggoner et al. (2007).  They found no 
significant differences for hot carcass weight, fat thickness, and calculated yield grade for 
healthy and treated steers.  We did find an agreement with the Waggoner et al. (2007) results in 
that we did not find a difference in longissimus muscle area due to morbidity.     
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We did see that net returns were decreased by $52.32 when an animal became sick (Table 
17).  This value is similar to those presented by Fulton et al. (2002).  Calves treated for BRD 
once returned $40.64 less, those receiving two medical treatments returned $58.35 less, and 
those receiving 3 or more treatments returned $291.93 less than calves that were not treated.   
USDA quality grade distribution differed significantly (P < 0.01) among morbidity 
categories (Table 18).  Yield grade was also significantly different which contrasts the findings 
of Waggoner et al. (2007) who found no differences in calculated yield grade.  We believe that 
we may have been able to find significant differences due to sample size.  To the best of our 
knowledge, this is the largest data set of this kind. 
Backgrounding period.  When backgrounding period was analyzed, it was found that pre-
feedlot backgrounding period affected several aspects of feedlot performance (Table 19).  Calves 
backgrounded for more than 21 days were 8.24 kg heavier than calves from any other 
backgrounding period at feedlot entry.  These calves also had the heaviest final body weights.  
Days on feed had a tendency (P = 0.09) to be affected by backgrounding period.  Calves 
backgrounded for less than 14 days had the least amount of days on feed at 189 d.  
Backgrounding period also significantly altered average daily gains.  Least squares means of 
average daily gains were 1.28, 1.35, 1.32, and 1.38 kg/d for the periods of not backgrounded, 1-
13 d, 14-20, and 21-45, respectively.  Backgrounding period caused a difference (P = 0.04) in 
percentage morbidity.  Morbidity for animals backgrounded for more than 21 d prior to feedlot 
entry was 18.45%; while morbidity for animals not backgrounded was 24.93%.   
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  Table 17.  The influence of morbidity on production and carcass traits of Texas A&M ranch to 
rail calves. 
 
 
Morbidity at 
feedyard         
Item  No  Yes  SE 
P‐
Value     
Number of calves  6215  1399  ‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐     
Performance             
    Initial BW, kg  270.26  269.42 4.96 0.82    
    Final BW, kg  536.41  528.41 4.95 <0.01    
    Days on Feed  191  197 1.45 <0.01    
    ADG, kg/d  1.33  1.28 0.02 0.04    
Carcass       
    HCW, kg  345.25  334.74 3.86 <0.01    
    Dressing Percent  63.91  63.24 0.22 0.01    
    LM area, cm2 84.62  85.59 1.16 0.49    
    Fat Thickness, 
cm  1.06  0.93 0.05 0.02    
    KPH, %  2.33  2.15 0.05 <0.01    
    USDA yield grade  2.38  2.14 0.08 <0.01    
Financial       
    Total COG ($ / lb)  0.52  0.58 0.01 <0.01    
    Medicine Cost 
($)  0  25.6 0.89 <0.01    
    Gross Return ($)  574.51  515.7 15.58 <0.01    
    Net Return ($) 1 138.46  86.14 10.95 <0.01    
             
             
1 Gross Return minus initial value of animal as determined by trained personnel 
 
 
 
129 
 
 
Table 18.  Influence of morbidity on quality grade of steers in the Texas A&M ranch to rail 
program. 
 
  Morbidity Category 1  
Item  Healthy  Sick   
Number of steers  6052  1354  
USDA quality grade  ‐‐‐‐‐‐‐‐‐‐‐%‐‐‐‐‐‐‐‐‐‐‐   
  Prime  0.38  0.07  
  Choice  42.3  30.8  
  Select  52.5  61.08  
  Standard  4.28  7.9  
  Dark Cutter  0.51  0.15  
  Hard Bone  0.03  0  
       
1 Number of medical treatments per head:   
  healthy = no treatment; sick = at least one treatment 
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Table 19.  The effects of backgrounding period on feedlot production and carcass traits of Texas 
A&M ranch to rail calves. 
 
     
 
Number of Days backgrounded prior 
to Shipping 1    
Item  None  1‐14  15‐21  > 21  SE 
P‐
Value 
Number of Steers  127  432 1011 3538 ‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐ 
Performance             
    Initial BW, kg  267.28  267.22 267.03 275.52 5.7  0.03 
    Final BW, kg  531.53  530.86 525.68 539.82 6.2  <0.01 
    Days on Feed  201  189 198 192 6.58  0.09 
    ADG, kg/d  1.28  1.35 1.32 1.38 0.02  <0.01 
    Percent Morbidity  24.93  22.72 22.79 18.45 3.91  0.04 
Carcass             
    HCW, kg  338.73  336.81 333.02 342.98 4.8  <0.01 
    Dressing Percent  63.55  63.6 63.25 63.34 0.25  0.32 
    LM area, cm2 84.83  84.08 84.07 85.36 1.3  0.31 
    Fat Thickness, cm  0.96  1.14 1.05 1.08 0.06  <0.01 
    KPH, %  2.34  2.2 2.15 2.15 0.04  <0.01 
    USDA yield grade  2.18  2.54 2.45 2.5 0.09  <0.01 
Financial             
    Total COG, $ / lb  0.55  0.55 0.55 0.55 0.01  0.91 
    Medicine Cost, $ / 
head  10.11  12.14 11.2 10.16 1.6  <0.01 
    Gross Return, $ / 
head  562.92  424.81 425.9 463.02 18.53  <0.01 
    Net Return, $ / head 2 127.06  48.71 26.24 65.16 14.4  <0.01 
 
1 Treatment groups: none (animals were weaned the day of shipping); 0-14 (animals were 
weaned for no more than 14 days prior to shipping); 14-21 (animals were weaned for no less 
than 14 d and no more than 21 d prior to shipping); and 21-45 (weaning to shipping time was 
greater than 21d and less than 45).   
 
2 Gross Return minus initial value of animal as determined by trained personnel 
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Carcass traits were also altered by backgrounding period prior to feedlot entry.  Hot carcass 
weights were heaviest for calves backgrounded for more than 21 d at 342.98 kg; however, these 
weights are similar to carcass weights of calves not backgrounded at 338.73 kg.  Dressing 
percentage and rib-eye area were not influenced by backgrounding period.  Animals 
backgrounded for no more than 14 days had the highest (P < 0.01) fat thickness measurements; 
this was followed by animals in the 21-45 group, then the 14-20 group, and finally by those not 
vaccinated.  Calves not backgrounded had lower (P < 0.01) yield grades than calves 
backgrounded.  Quality grade was influenced by backgrounding period and morbidity.  
Interaction results are shown in Table 20. 
Total cost of gain per animal was not different among backgrounding periods.  Net returns 
were significantly different among the groups when looking at main effects.  Since the 
interaction of backgrounding period and morbidity was significant (P = 0.03) we are reporting 
the net returns across the combinations in Figure 43.  In calves that were healthy, net returns 
were greatest for calves that were not backgrounded.  However, when sickness was encountered 
in the feedyard, non-backgrounded calves returned $28.74 less than calves backgrounded for 
more than 21 days.   
Of the 5,108 head entered into the program with complete backgrounding information, 69% 
(3,538) were backgrounded for more than 21 days; whereas, only 2.5% (127) were not 
vaccinated at all.  This could mean that for the backgrounding information, results could be 
skewed.  As we did not have control over backgrounding period, we have to analyze the data as 
it is.  Therefore, the results presented here are the best results that we can provide with the data 
set given. 
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1 Interaction between backgrounding period and  morbidity status of calf significant (P < 0.01). 
 
Figure 43.  Feedlot net returns of calves in the Texas A&M ranch to rail program. 1 
 
 
 
 
 
 
 
133
Table 20.  Effect of pre-feedlot backgrounding period on carcass quality of Texas A&M ranch to rail steers. 
 
  Backgrounding Period 1
  Healthy    Sick 
Item  None  0‐13  14‐20  21‐45    None  0‐13  14‐20  21‐45 
                  
Number of steers  95  343 797 2965   12 89  214 573
USDA quality 
grade  ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐%‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐    ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐%‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ 
  Prime  1.05  0.29 0.25 0.37   0 0  0 0.17
  Choice  55.79  35.28 33.12 46.48   33.33 26.97  26.64 33.86
  Select  38.95  59.18 59.72 48.60   50.00 64.04  59.81 56.72
  Standard  4.21  4.37 6.02 3.98   16.67 8.99  12.62 9.25
  Dark Cutter  0  0.87 0.88 0.54   0 0  0.93 0
  Hard Bone  0  0 0 0.03   0 0  0 0
 
1 Treatment groups: none (animals were weaned the day of shipping); 0-14 (animals were weaned for no more than 14 days prior to 
shipping); 14-21 (animals were weaned for no less than 14 d and no more than 21 d prior to shipping); and 21-45 (weaning to shipping 
time was greater than 21d and less than 45).   
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Step et al. (2008) reported the effects of different weaning protocols on feedlot performance 
during a 42 d receiving period.  They showed that on arrival, calves weaned for 45 d prior to 
feedlot entry and receiving a vaccination had higher (P < 0.01) body weights than calves weaned 
upon arrival.  Our results agree with their findings.  Calves weaned for greater than 21 d were 
significantly  (P < 0.03)  heavier at feedlot entry than calves not weaned prior to feedlot entry.  
This effect for increased body weights disappeared within 42 d after entry to the feedlot for the 
Step et al. (2008) project.  Our results, however, indicate that the differences in body weights 
remained throughout the feeding period.  Calves weaned for greater than 21 d were significantly 
heavier at the end of the study than those having been weaned for 14 to 21 d.  However, finishing 
weights in the animals in the 21-45 d group were similar to those weaned for less than 14 d.   
We were able to show that percentage morbidity was influenced by number of days 
backgrounded prior to shipping.  Animals weaned more than 21 d prior to entry into the feedlot 
were less morbid than those weaned at time of shipping.  Fulton et al. (2002) showed that the 
timing of vaccine administration in the herds with the lowest morbidity rates was alike: herd 1 
received an MLV vaccine with the 4 viruses (IBR, BVD1a, PI3, and BRSV) approximately 7 and 
3 wk before delivery; herd 2 received a MLV vaccine with the same 4 viruses approximately 7 
wk before delivery; and herd 12 received a killed-virus vaccine with the same 4 viruses plus a M. 
haemolytica approximately 6 and 4 wk before delivery.  This is also in agreement with the 
findings of Step et al. (2008) if we assume their morbidity rates follow through the end of the 
feeding period.  Because of the interaction of net returns and morbidity, we found that in healthy 
calves, net returns were greatest for animals being weaned on the truck.  However, when 
sickness occurred, animals backgrounded for more than 21d had the highest net returns.  
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Depending upon a feedlot manager’s aversion to risk and ability to manage sick cattle, premium 
differences may occur depending upon length of backgrounding period.   
Dhuyvetter et al. (2005) were able to put a value on these premiums offered by the feedlot.  
They suggested that based on a 45 d postweaning preconditioning program, cow/calf producers 
can realize a $14.00 increase in returns compared with the sale of calves at weaning that are not 
preconditioned.  The differential in price between our returns and the premium paid by feedlot 
suggest that the majority of feedlots are working on the imperfect knowledge of where most of 
their cattle come from.  USDA-APHIS (2000) reported that only 32.4% of all feedlots surveyed, 
received information about the previous history of the calves “always or most of the time”.  Duff 
and Galyean (2007) suggest that perhaps improved information flow regarding the background 
of the cattle will result from the greater national emphasis on individual animal identification and 
trace-back, which might stimulate the demand for preconditioned calves; thus it may decrease 
the difference between the net returns we found and the premiums paid to producers.  It is 
possible that other market factors are also influencing the premiums paid.  Time of year, 
economic status, and price of corn may all effect price differences paid for backgrounded cattle.  
King et al. (2006) reported that price premiums for calves in intensive certified health programs 
ranged from $2.74 per 45.45 kg to $7.91 per 45.45 kg from 1995 to 2004.   
Pre-feedlot nutrition.  Producers were asked to describe their nutritional strategies prior to 
sending the calves to the feedyard.  Almost 3,000 cattle were reported to have been allowed to 
graze forage while being supplemented with some type of supplement (Table 21).  We did not 
have pre-feedlot feeding information on 2,194 animals.   
Pre-feedlot nutrition tended (P = 0.07) to have an effect on initial body weight.  Calves held 
in a drylot, receiving hay and a supplement were lightest at the initiation of the feeding period.   
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Table 21.  Effect of nutrition on production and carcass characteristics of beef steers in the Texas A&M ranch to rail program. 
 
  Weaning Period Feeds 1    
Item  Pasture
Past + 
Supp 
Dry + 
Hay  Dry+ Hay + Supp 
Drylot + 
TMR 
Not 
Reported  SEM  P‐Value 
Number of Steers  603 2994 273 1311  239 2194 ‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐ 
Performance           
   
     
               
     
    Initial BW, kg  277.80 280.99 288.77 268.39  276.95 277.14 10.50 0.07
    Final BW, kg  538.23 534.50 529.64 528.17  530.59 538.98 10.90 0.47
    Days on Feed  192 194 186 196  195 196 7.46 0.86
    ADG, kg/d  1.35 1.33 1.28 1.31  1.31 1.33 0.04 0.76
    Percent Morbidity 
 
15.74 16.37
 
17.33 16.31 
 
23.99
 
34.70
 
7.09 <0.01
Carcass  
    HCW, kg  350.23 347.17 337.32 342.79  343.52 350.92 5.49 0.16
    Dressing Percent  64.32 64.23 63.32 64.18  64.20 64.80 0.43 <0.01
    LM area, cm2 88.10 87.28 91.77 86.97  85.62 89.20 1.61 0.04
    Fat Thickness, cm  0.95 1.02 0.88 1.08  1.09 1.17 0.07 <0.01
    KPH, %  2.06 2.08 2.22 2.11  2.13 2.11 0.06 0.42
    USDA yield grade 
 
2.36 2.42
 
1.93 2.45  2.47
 
2.24
 
0.17 0.01
Financial  
    Total COG, $ / lb  0.54 0.55 0.53 0.54  0.54 0.64 0.02 <0.01
    Medicine Cost, $ / head  12.58 11.19 9.06 11.63  7.91 11.89 3.84 0.75
    Gross Return, $ / head  510.90 502.76 484.88 493.52  517.77 383.54 23.37 <0.01
    Net Return, $ / head 2 114.75 90.63 78.24 96.64  69.55 21.40 23.70 <0.01
 
1 Feeding strategies were: Pasture (Pasture only); Past + Supp (Pasture plus a supplement);  Dry + Hay (Drylot plus hay); Dry + Hay 
+ Supp (Drylot plus Hay plus a supplement);  Drylot + TMR (Drylot plus total mixed ration); Not Reported (Background feeding 
information not available)  
 2 Gross Return minus initial value of animal as determined by trained personnel.
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Least squares means for the initial body weights ranged from 268.39 kg for the dry + hay + supp 
category, to 288.77 kg for the dry + hay group.  No differences were seen in the final body 
weights, days on feed, or average daily gains.  Percentage morbidity was significantly influenced 
by pre-feedlot feeding strategies.  Calves grazing only pasture prior to entry had a 15.74% 
morbidity rate while those held in a drylot and fed a total mixed ration (TMR) had a 24% 
morbidity rate.  Calves from producers not reporting their feeding strategies had the highest 
morbidity rates at 34.7%. 
Several carcass traits were influenced by pre-feedlot feeding strategies.    Dressing 
percentage, fat thickness, and yield grades were significantly different among treatment groups.  
Cattle receiving hay in a drylot had the lowest yield grades.  Yield grades were highest for calves 
held in a drylot and received a TMR.  Calves that only grazed pasture returned an additional 
$45.20 in profit over calves that were held in a drylot and fed a total mixed ration prior to entry 
into the feedlot.  Calves of producers not reporting their feeding strategies, had the lowest net 
returns of the treatment groups.  Hot carcass weight and KPH were not affected by pre-feedlot 
nutrition.  
Few research projects set out to determine the difference in the pre-feedlot nutrition 
programs.  Most research programs assume that if calves are pre-conditioned for a certain 
amount of time and vaccinated that calves will have similar results in the feedlot.  Our results 
contradict this assumption.  We found that calves coming from a pasture only program had 
increased net returns in the feedlot over that of calves placed on drylot during the pre-
conditioning program.  This is most likely due to the difference in morbidity seen between the 
two groups.  A sensitivity analysis by Macartney et al. (2003) indicated that morbidity rate had a 
great influence on profitability.  Calves backgrounded on pasture only had much lower morbidity 
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rates at 15.74%  than that of drylot fed calves (24%).  This agrees with the findings of St. Louis 
et al. (2003) who found that pre-conditioning calves on ryegrass pastures resulted in greater 
ADG and decreased feed costs compared with preconditioning in a drylot.  They, like us, were 
not able to determine whether the improved performance on grass was a result of decreased 
morbidity or other factors. 
Viral and clostridial vaccines.  All calves received at least two injections prior to entry into 
the program.  The type of vaccine given in these injections varied greatly.  Some producers gave 
as many as 8 injections prior to sending their calves to the feedlot ; 88.6% of the cattle received 
at least a clostridial vaccine while 86% received at least a viral vaccine to bovine respiratory 
disease, and 70.1% (5,338) received both a clostridial vaccine and a viral vaccination prior to 
entry into the feedlot (Table 22).  Receipt of either a clostridial or a viral vaccine did not 
influence weight of the calves at feedlot entry or exit.  The feedlot production parameters of days 
on feed, average daily gains, and percent morbidity were also not significantly altered by receipt 
of either a clostridial or viral vaccine.  No carcass characteristics differed (P < 0.10) due to 
receipt of vaccination prior to entry into the feedyard.  However, medicine cost was significantly 
different for calves that received a viral vaccine over that of calves not receiving a vaccination.  
Mean medicine costs for calves receiving a viral vaccine was $10.52 per head while the mean for 
those not receiving a vaccination was $12.71 per head.  Total cost of gain and net returns were 
not influenced by receipt of a viral or clostridial vaccine prior to entry into the feedlot. 
A previous study of the cow-calf segment revealed that approximately 60% of producers 
vaccinated calves for clostridial diseases before weaning (NAHMS, 1994).  We found that 89% 
of producers enrolling in this program vaccinated for clostridial diseases.  As the majority of 
producers enrolled in this program are concerned about how their cattle perform in the feedlot,  
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Table 22.  Production and carcass responses of steers in the Texas A&M ranch to rail program to 
clostridial and viral vaccines given prior to feedlot entry 1. 
 
  Clostridial      Viral   
Item  No  Yes  SE    No  Yes  SE 
Interaction 
P‐Value 
Number of Steers  864  6750     1059 6555  ‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐ 
Performance                 
    Initial BW, kg  280.75  274.56 6.05   276.67 278.63  5.65  0.37
    Final BW, kg  532.96  531.80 6.96   529.97 534.79  6.51  0.82
    Days on Feed  188  193 7.42   187 195  7.38  0.48
    ADG, kg/d  1.31  1.32 0.02   1.30 1.32  0.02  0.86
    Percent Morbidity  14.96  18.67 5.70   16.48 17.15  1.90  0.80
Carcass                 
    HCW, kg  343.52  341.40 4.15   341.68 343.24  3.80  0.96
    Dressing Percent  64.17  64.00 0.27   64.36 63.82  0.20  0.03
    LM area, cm2 87.46  88.11 1.20   87.58 87.99  1.15  0.77
    Fat Thickness, cm  1.01  1.01 0.05   1.03 1.00  0.05  0.58
    KPH, %  2.07  2.06 0.04   2.07 2.06  0.04  0.50
    USDA yield grade  2.33  2.28 0.10   2.31 2.29  0.09  0.95
Financial                 
    Total COG, $ / lb  0.56  0.57 0.01   0.56 0.57  0.01  0.54
    Medicine Cost, $ / 
head  11.89  11.34 1.24   12.71 10.52  1.12  0.06
    Gross Return, $ / 
head  467.23  457.89 19.90   472.92 452.20  18.64  0.96
    Net Return, $ / head 2 55.46  68.97 15.12   68.35 56.09  14.16  0.58
 
1 Additional viral and clostridial vaccinations given at feedlot entry. 
2 Gross Return minus initial value of animal as determined by trained personnel. 
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we believe that they may not be a true representative sample the proportion of producers 
vaccinating for clostridials.  The producers in this program are trying to improve their 
management practices, and may therefore, have already implemented the policy of giving 
clostridial vaccines to their calves prior to shipping.   
We were not able to find in this study differences in production or carcass data with 
clostridial and viral vaccine as treatment.  This is surprising.  Macartney et al. (2003) showed 
that in 1999 and 2000, animals that were vaccinated had decreased morbidity rates of 7.1 and 
5.4% respectively.  We found that, while not significantly different, animals receiving a 
clostridial or viral vaccine prior to feedlot entry actually had higher morbidity rates.  We cannot 
explain this.  However, as all animals received both a clostridial and a viral vaccination at feedlot 
entry it could be possible that vaccination at feedlot arrival was able to protect the cattle from 
disease no matter the vaccination sequence prior to feedlot entry.   
Type of viral vaccine.  When we evaluated calves that had received a viral vaccine for the 
type of vaccine that they received, we found no differences (P < 0.01) among the parameters that 
we measured (Table 23).  There was a tendency (P = 0.11) for average daily gains to be 
influenced by type of viral vaccine given prior to feedlot entry.  Calves receiving only a killed 
vaccine had the highest ADG at 1.48 kg/d while those receiving both a killed and a MLV had the 
lowest at 1.36 kg/d.  Least squares means of type of viral vaccine for feedlot entry body weights 
ranged from 271.31 to 295.23 kg.  Feedlot morbidity was not influenced by type of viral vaccine 
given prior to feedlot entry.  Those calves in the Kill treatment group had morbidity rates of 
12.4% while those in the Kill + MLV group had rates of 25.13%.  Net returns were not 
significantly different among treatment groups.  However, animals that received only a killed 
vaccine prior to feedlot entry returned $80.13 while those receiving a combination of killed and a 
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Table 23.  Effect of various types of viral vaccines on carcass traits and production responses of 
beef calves in the Texas A&M ranch to rail program. 
 
  Viral Vaccine 1    
Item  Alt  Kill  MLV  Alt + MLV  Kill + MLV  SE  P‐Value 
Number of Steers  1283  685 3556 401 321  ‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐ 
Performance               
    Initial BW, kg  276.26  271.31 281.32 278.79 295.23  13.08 0.36
    Final BW, kg  537.17  557.74 542.61 543.53 545.51  13.94 0.14
    Days on Feed  196  202 193 193 186  5.65 0.51
    ADG, kg/d  1.38  1.48 1.39 1.39 1.36  0.03 0.11
    Percent Morbidity  19.27  12.4 17.65 17.86 25.13  9.01 0.69
Carcass               
    HCW, kg  344.43  357.77 346.79 344.64 352.86  8.92 0.15
    Dressing Percent  63.94  64.13 63.81 63.44 64.34  0.59 0.49
    LM area, cm2 86.55  88.5 87.4 88.69 92.02  2.72 0.23
    Fat Thickness, cm  1.04  1.2 1.07 1.01 1.07  0.12 0.25
    KPH, %  2.12  2.17 2.09 2.12 1.99  0.08 0.29
    USDA yield grade  2.38  2.56 2.38 2.3 2.19  0.13 0.54
Financial               
    Total COG, $ / lb  0.56  0.53 0.57 0.57 0.61  0.04 0.24
    Medicine Cost, $ / 
head  11.59  8.15 10.07 11.94 7.41  4.38 0.64
    Gross Return, $ / 
head  439.94  485.98 437.6 447.66 449.55  24.36 0.4
    Net Return, $ / head 2 57.62  80.13 42.88 36.5 16.97  18.56 0.15
 
1 Treatments include: Kill (killed vaccine); MLV (modified-live virus vaccine); Alt (altered 
vaccine); Alt + MLV (combination of Alt and MLV); Kill + MLV (combination of Kill and 
MLV). 
 
2 Gross Return minus initial value of animal as determined by trained personnel. 
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MLV vaccine returned only $16.97.  Medicine cost per animal was lowest for the kill + MLV 
treatment category.   
There was an interaction between morbidity and net returns (Figure 44).  When animals 
remained healthy throughout the feeding period, net returns for animals in the kill+MLV 
treatment group were significantly lower than those in the kill group.  When the animal became 
sick, returns were greatest for animals in the kill group.  Animals in both the kill+MLV group 
and in the Alt+MLV group were similar for net returns.  They were both significantly less than 
the kill group.  Animals in the MLV and Alt only groups were intermediate to these. 
Strategies to control respiratory viruses are a key component in preventing BRD (Grooms 
and Coe, 2002).  In most preconditioning programs, it is recommended that cattle receive a viral 
vaccination prior to feedlot entry.  Vaccines and vaccination protocols vary tremendously and are 
often debated by veterinarians and producers.  Grooms and Coe, (2002) reported that frequently 
these protocols are based on extrapolation of data from unrelated studies or experiences, and 
there is a lack of critical evaluation and comparison among different vaccination protocols that 
focus on optimizing immunity in the preconditioned calf.   
 We evaluated the different vaccination protocols for viral vaccination used in calves prior 
to entry into the feedlot.  No differences existed among the viral vaccinations.  These results 
agree with Grooms and Coe (2002) who report that significant differences in ADG among the 
nine vaccine groups were not detected during the study.  Furthermore, they report that 
vaccination protocols for BVDV and BHV-1 that include at least one MLV stimulate the highest 
levels of serum-neutralizing antibodies.  We might assume, that as all animals received a MLV 
when they reached the feedyard, that the animals received their pre-conditioning vaccinations 
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Figure 44.  Feedlot net returns of various viral vaccination combinations on healthy and sick 
steers in the Texas A&M ranch to rail program1.  
 
1 Treatments include: Kill (killed vaccine); MLV (modified-live virus vaccine); Alt (altered 
vaccine); Alt + MLV (combination of Alt and MLV); Kill + MLV (combination of Kill and 
MLV). 
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plus a booster when arriving at the feedyard.  Therefore, all the calves maximized their antibody 
titer response because of the vaccination at the feedlot and not at the ranch level.    
The vaccination regimens differed, particularly in the number of vaccinations and the timing 
of vaccination administration.  Some producers only gave 2 shots while others gave as many as 8 
shots.  Fulton et al. (2002) reported that a particular vaccine may not be as important as timing of 
vaccination administration.  We were not able to measure timing of vaccine administration. 
However, if the Fulton et al. (2002) conjecture is correct, it may explain why we found no 
differences among types of viral vaccinations given.  Even if we had the dates of vaccination, we 
may not be able to differentiate among vaccination strategies as it would be highly confounded 
with backgrounding period.   
Other vaccinations.  Upon evaluation of other vaccinations (not viral or clostridial) given to 
animals prior to feedlot entry, we found no differences due to an additional lepto or somnus 
vaccine (Table 24).  For all response variables, no treatment by morbidity interaction occurred 
due to treatment with a lepto or somnus vaccine.   
Correlations.  Pearson correlations (seen in Table 25) among response variables were highly 
significant (P < 0.001).  Hot carcass weights were correlated to ADG at 0.65.  Medicine costs 
were negatively correlated with net returns.  ADG and HCW were positively correlated to net 
returns.  Days on feed was correlated with initial weight at -0.62.  We did not find the 
correlations with initial weight as Zinn et al. (2008) found.  We were not able to find strong 
correlations between hot carcass weight, ADG and initial weight.  In that study they used shrunk 
initial weight which may have created some of the differences between the two studies.  
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Table 24.  Feedlot production responses of various vaccinations given (other than a viral or 
clostridial vaccine) to calves in the Texas A&M ranch to rail program. 
 
  Vaccine 1    
     
Item  Lepto  Somnus
Lepto + 
Somnus None  SE 
P‐
Value 
Number of Steers  764  1980 530 4340 ‐‐‐‐‐‐  ‐‐‐‐‐‐ 
Performance             
    Initial BW, kg  282.52  274.95 272.42 270.74 4.83 0.28 
    Final BW, kg  539.87  543.24 540.78 540.36 5.84 0.95 
    Days on Feed  193  194 196 195 2.88 0.90 
    ADG, kg/d  1.34  1.39 1.40 1.37 0.02 0.12 
    Percent Morbidity  17.11  17.34 23.79 20.22 3.30 0.35 
Carcass             
    HCW, kg  344.38  347.32 344.71 344.87 3.43 0.83 
    Dressing Percent  63.67  63.71 63.71 63.42 0.20 0.80 
    LM area, cm2 86.28  87.62 88.00 88.13 0.99 0.49 
    Fat Thickness, cm  0.99  1.09 0.97 1.03 0.05 0.08 
    KPH, %  2.05  2.07 2.01 2.10 0.03 0.43 
    USDA yield grade  2.37  2.39 2.23 2.25 0.08 0.28 
Financial             
    Total COG, $ / lb  0.57  0.55 0.57 0.59 0.01 0.22 
    Medicine Cost, $ / 
head  10.98  9.90 11.39 11.26 0.80 0.29 
    Gross Return, $ / 
head  464.99  460.10 463.38 438.46 15.63 0.70 
    Net Return, $ / head 2 54.92  66.09 67.84 51.92 11.99 0.66 
   
1 This vaccine given in addition to a 7 or 8-way clostridial  
   
  2 Treatments include: Lepto (a clostridial plus lepto-spirosis); Somnus (a clostridial plus 
Haemophilus somnus); Lepto+Somnus (a clostridial plus both Lepto and Somnus); none (only 
receiving a clostridial). 
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Table 25.  Correlations among production traits and carcass characteristics of Texas A&M ranch to rail steers. 
 
 
  InWt  OutWt  ADG  Dress  HCW  YG  Med  
InWt               
OutWt  0.43             
ADG  0.09  0.74           
Dress  0.09             ‐0.04 ‐0.12
HCW  0.45  0.93  0.65  0.34      
YG  0.08  0.23  0.2  0.11 0.26    
Med   ‐0.08     ‐0.04 ‐0.07 ‐0.14 ‐0.11 ‐0.09  
Net  0.08  0.46  0.55  0.25 0.53 0.13 ‐0.26               
             
   
           
 
1 Abbreviations: InWt (initial weight); OutWt (final weight); ADG (average daily gain, kg/d); Dress (dressing percentage); HCW 
(hot carcass weight, kg); YG (calculated yield grade); Med (medicine cost, $ / head); Net (net return, $/head) 
         
2 All significant at the P < 0.0001 level 
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Conclusions 
As producers question the profitability of preconditioning programs, it is important to detail 
how producer management decisions affect feedlot production.  These data help to assign value 
to management decisions at the cow/calf level that effect feedlot returns.  Morbidity in the 
feedyard significantly affects yield grade, quality grade, medicine costs, gross returns and net 
returns.  Morbidity is influenced by the amount of time that a calf is backgrounded prior to entry 
into the feedlot.  Value of backgrounding period is highly dependent upon whether or not the calf 
gets sick.  If the calf remains healthy, calves not backgrounded return the most money.  
However, if the calf does get sick, then calves that were backgrounded for more than 21 d are 
most valuable.  Therefore, levels of morbidity in the feedyard is highly correlated with how 
much risk feedlot management is willing to accept.   
Cattle backgrounded on pasture only were more profitable to feedlots than calves that are 
backgrounded in a drylot.  In this study, vaccination prior to feedlot entry did not alter 
production of the cattle in the feedlot as long as the calf receives the vaccination at the feedlot.  
However, due to the large numbers of animals vaccinated and backgrounded and the relatively 
few animals not vaccinated or backgrounded, we cannot definitively say that vaccination prior to 
feedlot entry does not work because of confounding in the data.   
Many research trials show that it is possible to induce immunity in cattle with vaccinations 
prior to feedlot entry.  On the basis of disease containment, we must continue to recommend that 
cattle are vaccinated as early in life as possible.  Vaccinating prior to feedlot entry does not cause 
any disadvantages once the animal reaches the feedlot. 
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CHAPTER VII 
DISSERTATION SUMMARY 
 
The segments of the beef industry are intrinsically linked together.  Management decisions at 
one level alter the value of the product at other levels.  In this dissertation, we discussed each 
segment as an individual entity as well as looked at connections between the levels.   
Results of the experiments conducted show that vaccination of an animal at a young age is 
critical to the economic return seen when the animal is harvested at the conclusion of the feedlot 
experience.  While vaccination in itself is critical, type of vaccination is also important.  
Different vaccines have differential effects on the magnitude and timing of release of various 
cytokines.  These differences may in part be due to differences in the development of the calf’s 
own immune system.  We showed that it is possible to vaccinate a calf within the first three days 
of birth and get an immune response; but that it may be more beneficial to the calf’s own 
immune system development, to wait to vaccinate the calf until it is somewhat older 
(approximately 3 to 5 months of age).   
When vaccinations were given to older cattle, we found that due to size and age differences, 
animals responded differently to the vaccine.  While in the early periods of the feeding phase, 
performance differences did exist, the differences disappeared by the end of the trial.  As the 
vaccines all stimulated adequate antibody production, differences in early weight gains and the 
length of time and/or phase of ownership may be a driver in the decision as to which vaccine 
should be used.  
Length of time that a calf is backgrounded also affects the economic value of the calf at the 
end of the feeding period.  Morbidity in the feedyard significantly affects yield grade, quality 
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grade, medicine costs, gross returns and net returns.  Morbidity is directly influenced by the 
amount of time that a calf is backgrounded prior to entry into the feedlot.  Type of 
backgrounding program also influences profitability of the animal.  Cattle backgrounded on 
pasture only were more profitable to feedlots than calves that are backgrounded in a drylot.  This, 
therefore, affects that value at which the feedlot can pay the producer for the animal. 
The data gathered here suggest that strong relationships exist between management decisions 
and resulting economic returns of the animals.  As each segment of the industry is inherently 
linked to all other segments, it is important for all involved to start to recognize how their 
decisions impact others. 
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